UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | V | W | Y | Z
Number of items: 359.

A

Abell, K; Bilancio, A; Clarkson, RWE; Tiffen, PG; Altaparmakov, AI; Burdon, TG; Asano, T; (2005) Stat3-induced apoptosis requires a molecular switch in PI(3)K subunit composition. NATURE CELL BIOLOGY , 7 (4) pp. 392-398. 10.1038/ncb1242.

Abelman, W; Virchis, A; Yong, K; (2005) Extramedullary myeloma representing as a pericardial effusion with tamponade: Two case reports and a further review of 19 cases in the literature. LEUKEMIA & LYMPHOMA , 46 (1) pp. 137-142. 10.1080/10428190400011583.

Addison, EG; North, J; Bakhsh, I; Marden, C; Haq, S; Al-Sarraj, S; Malayeri, R; (2005) Ligation of CD8 alpha on human natural killer cells prevents activation-induced apoptosis and enhances cytolytic activity. IMMUNOLOGY , 116 (3) 354 - 361. 10.1111/j.1365-2567.2005.02235.x. Gold open access

Adib, T.R.; (2005) Gene expression microarrays of serous ovarian adenocarcinoma. Doctoral thesis, University of London. Green open access
file

Aebischer, T; Bennett, CL; Pelizzola, M; Vizzardelli, C; Pavelka, N; Urbano, M; Capozzoli, M; (2005) A critical role for lipophosphoglycan in proinflammatory responses of dendritic cells to Leishmania mexicana. EUROPEAN JOURNAL OF IMMUNOLOGY , 35 (2) pp. 476-486. 10.1002/eji.200425674.

Agresti, A; Scaffidi, P; Riva, A; Caiolfa, VR; Bianchi, ME; (2005) GR and HMGB1 interact only within chromatin and influence each other's residence time. MOLECULAR CELL , 18 (1) pp. 109-121. 10.1016/j.molcel.2005.03.005.

Ahmed, F.; (2005) Homing and engraftment of CD34+ cells in the NOD/SCID model. Doctoral thesis, University of London. Green open access
file

Amis-, SJ; Coulter-Smith, SD; Crow, JC; Maclean, AB; Perrett, CW; (2005) Microvessel quantification in benign and malignant ovarian tumors. INT J GYNECOL CANCER , 15 (1) 58 - 65.

Arce, F; Gätjens-Boniche, O; Vargas, E; Valverde, B; Díaz, C; (2005) Apoptotic events induced by naturally occurring retinoids ATRA and 13-cis retinoic acid on human hepatoma cell lines Hep3B and HepG2. Cancer Lett , 229 (2) pp. 271-281. 10.1016/j.canlet.2005.06.047.

Ardeshna, KM; Kakouros, N; Qian, W; Powell, MG; Saini, N; D'Sa, S; Mackinnon, S; (2005) Conventional second-line salvage chemotherapy regimens are not warranted in patients with malignant lymphomas who have progressive disease after first-line salvage therapy regimens. BRIT J HAEMATOL , 130 (3) 363 - 372. 10.1111/j.1365-2141.2005.05603.x.

Arkenau, HT; Müssig, O; Buhr, T; Jend, HH; Porschen, R; (2005) Microangiopathic hemolytic anemia (MAHA) as paraneoplastic syndrome in metastasized signet ring cell carcinomas: case reports and review of the literature. Z Gastroenterol , 43 (8) pp. 719-722. 10.1055/s-2005-858259.

Arkenau, HT; Rettig, K; Porschen, R; (2005) Adjuvant chemotherapy in curative resected colon carcinoma: 5-fluorouracil/leucovorin versus high-dose 5-fluorouracil 24-h infusion/leucovorin versus high-dose 5-fluorouracil 24-h infusion. Int J Colorectal Dis , 20 (3) pp. 258-261. 10.1007/s00384-004-0657-6.

Arno, G; Kaski, JC; Smith, DA; Akiyu, JP; Hughes, SE; Baboonian, C; (2005) Matrix metalloproteinase-9 expression is associated with the presence of Chlamydia pneumoniae in human coronary atherosclerotic plaques. Heart , 91 (4) pp. 521-525. 10.1136/hrt.2003.012054.

Azzabi, A; Hughes, AN; Calvert, PM; Plummer, ER; Todd, R; Griffin, MJ; Lind, MJ; (2005) Phase I study of temozolomide plus paclitaxel in patients with advanced malignant melanoma and associated in vitro investigations. BRIT J CANCER , 92 (6) 1006 - 1012. 10.1038/sj.bjc.6602438.

B

Barber, LJ; Ward, TA; Hartley, JA; McHugh, PJ; (2005) DNA interstrand cross-link repair in the Saccharomyces cerevisiae cell cycle: Overlapping roles for PSO2 (SNM1) with MutS factors and EXO1 during S phase. MOL CELL BIOL , 25 (6) 2297 - 2309. 10.1128/MCB.25.6.2297-2309.2005. Gold open access

Bartesaghi, S; Marinovich, M; Corsini, E; Galli, CL; Viviani, B; (2005) Erythropoietin: A novel neuroprotective cytokine. NEUROTOXICOLOGY , 26 (5) 923 - 928. 10.1016/j.neuro.2005.01.016.

Bates, AW; (2005) Emblematic monsters: unnatural conceptions and deformed births in early modern Europe. (Vol.77).

Bates, AW; (2005) Good, common, regular, and orderly: Rarly modern classifications of monstrous births. SOC HIST MED , 18 (2) 141 - 158. 10.1093/sochis/hki029.

Bates, AW; Nale, K; (2005) Segmentation defects of the human axial skeleton without dysostoses or skeletal dysplasias. FETAL PEDIATR PATHOL , 24 (2) 121 - 127. 10.1080/15227950500257333.

Bell, CG; Meyre, D; Samson, C; Boyle, C; Lecoeur, C; Tauber, M; Jouret, B; (2005) Association of melanin-concentrating hormone receptor 1 5' polymorphism with early-onset extreme obesity. Diabetes , 54 (10) pp. 3049-3055.

Bell, CG; Walley, AJ; Froguel, P; (2005) The genetics of human obesity. Nat Rev Genet , 6 (3) pp. 221-234. 10.1038/nrg1556.

Bengala, C; Guarneri, V; Ledermann, J; Rosti, G; Wandt, H; Lotz, JP; Cure, JH; (2005) High-dose chemotherapy with autologous haemopoietic support for advanced ovarian cancer in first complete remission: retrospective analysis from the Solid Tumour Registry of the European Group for Blood and Marrow Transplantation (EBMT). BONE MARROW TRANSPLANTATION , 36 (1) pp. 25-31. 10.1038/sj.bmt.1705007.

Bennett, CL; van Rijn, E; Jung, S; Inaba, K; Steinman, RM; Kapsenberg, ML; Clausen, BE; (2005) Inducible ablation of mouse Langerhans cells diminishes but fails to abrogate contact hypersensitivity. JOURNAL OF CELL BIOLOGY , 169 (4) pp. 569-576. 10.1083/jcb.200501071. Green open access
file

Bilanges, B; Stokoe, D; (2005) Direct comparison of the specificity of gene silencing using antisense oligonucleotides and RNAi. Biochem J , 388 (Pt 2) pp. 573-583. 10.1042/BJ20041956.

Birtle, AJ; Freeman, A; Masters, JRW; Payne, HA; Harland, SJ; Baus Section Oncology Canc Registr, ; (2005) Tumour markers for managing men who present with metastatic prostate cancer and serum prostate-specific antigen levels of < 10 ng/mL. BJU INT , 96 (3) 303 - 307. 10.1111/j.1464-410X.2005.05619.x.

Boddy, AV; Plummer, ER; Todd, R; Sludden, J; Griffin, M; Robson, L; Cassidy, J; (2005) A phase I and pharmacokinetic study of paclitaxel poliglumex (XYOTAX), investigating both 3-weekly and 2-weekly schedules. CLIN CANCER RES , 11 (21) 7834 - 7840. 10.1158/1078-0432.CCR-05-0803.

Bowen, DT; Frew, ME; Hills, R; Gale, RE; Wheatley, K; Groves, MJ; Langabeer, SE; (2005) RAS mutation in acute myeloid leukemia is associated with distinct cytogenetic subgroups but does not influence outcome in patients younger than 60 years. BLOOD , 106 (6) 2113 - 2119. 10.1182/blood-2005-03-0867.

Bower, M; Gazzard, B; Mandalia, S; Newsom-Davis, T; Thirlwell, C; Dhillon, T; Young, AM; (2005) A prognostic index for systemic AIDS-related non-Hodgkin lymphoma treated in the era of highly active antiretroviral therapy. ANN INTERN MED , 143 (4) 265 - 273.

Bower, M; Nelson, M; Young, AM; Thirlwell, C; Newsom-Davis, T; Mandalia, S; Dhillon, T; (2005) Immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma. J CLIN ONCOL , 23 (22) 5224 - 5228. 10.1200/JCO.2005.14.597.

Bower, M; Powles, T; Stebbing, J; Thirlwell, C; (2005) Potential antiretroviral drug interactions with cyclophosphamide, doxorubicin, and etoposide. J CLIN ONCOL , 23 (6) 1328 - 1329. 10.1200/JCO.2005.05.128.

Boxer, GM; Tsiompanou, E; Levine, T; Watson, R; Begent, RHJ; (2005) Immunohistochemical expression of vascular endothelial growth factor and microvessel counting as prognostic indicators in node-negative colorectal cancer. TUMOR BIOL , 26 (1) 1 - 8. 10.1159/000084180.

Boyer, LA; Lee, TI; Cole, MF; Johnstone, SE; Levine, SS; Zucker, JP; Guenther, MG; (2005) Core transcriptional regulatory circuitry in human embryonic stem cells. Cell , 122 (6) pp. 947-956. 10.1016/j.cell.2005.08.020.

Brandts, CH; Bilanges, B; Hare, G; McCormick, F; Stokoe, D; (2005) Phosphorylation-independent stabilization of p27kip1 by the phosphoinositide 3-kinase pathway in glioblastoma cells. J Biol Chem , 280 (3) pp. 2012-2019. 10.1074/jbc.M408348200.

Braybrooke, JP; Slade, A; Deplanque, G; Harrop, R; Madhusudan, S; Forster, MD; Gibson, R; (2005) Phase I study of MetXia-P450 gene therapy and oral cyclophosphamide for patients with advanced breast cancer or melanoma. Clin Cancer Res , 11 (4) pp. 1512-1520. 10.1158/1078-0432.CCR-04-0155.

Brenner, C; Deplus, R; Didelot, C; Loriot, A; Vire, E; De Smet, C; Gutierrez, A; (2005) Myc represses transcription through recruitment of DNA methyltransferase corepressor. EMBO J , 24 (2) 336 - 346. 10.1038/sj.emboj.7600509.

Brittan, M.; (2005) Bone marrow cells contribute to tissue regeneration in the intestine and skin. Doctoral thesis, University of London. Green open access
file

Brown, P; Marafioti, T; Kusec, R; Banham, AH; (2005) The FOXP1 transcription factor is expressed in the majority of follicular lymphomas but is rarely expressed in classical and lymphocyte predominant Hodgkin's lymphoma. J Mol Histol , 36 (4) pp. 249-256. 10.1007/s10735-005-6521-3.

Buchmueller, KL; Taherbhai, Z; Howard, CM; Bailey, SL; Nguyen, B; O'Hare, C; Hochhauser, D; (2005) Design of a hairpin polyamide, ZT65B, for targeting the inverted CCAAT box (ICB) site in the multildrug resistant (MDR1) gene. CHEMBIOCHEM , 6 (12) 2305 - 2311. 10.1002/cbic.200500179.

Burton, C; Smith, P; Vaughan-Hudson, G; Qian, W; Hoskin, P; Cunningham, D; Hancock, B; (2005) Comparison of CHOP versus CIOP in good prognosis younger patients with histologically aggressive non-Hodgkin lymphoma. Br J Haematol , 130 (4) pp. 536-541. 10.1111/j.1365-2141.2005.05640.x.

C

CHICKEN, DW; FALZON, M; KOCJAN, G; DOUEK, M; SAINSBURY, JRS; KESHTGAR, MRS; (2005) Intraoperative Touch Imprint Cytology of Clinically Apparently Involved Sentinel Node Metastases: Why Bother?. In: (pp. p. 31).

Cairo, S; De Falco, F; Pizzo, M; Salomoni, P; Pandolfi, PP; Meroni, G; (2005) PML interacts with Myc, and Myc target gene expression is altered in PML-null fibroblasts. ONCOGENE , 24 (13) 2195 - 2203. 10.1038/sj.onc.1208338.

Calvert, AH; (2005) Fishing for new drugs. J CLIN ONCOL , 23 (31) 7780 - 7782. 10.1200/JCO.2005.08.004.

Camilleri, RS; Cohen, H; (2005) No association between pulmonary embolism or deep vein thrombosis and the -455G/A beta-fibrinogen gene polymorphism. BLOOD COAGUL FIBRIN , 16 (3) 193 - 198.

Capponcelli, S; Pedrini, E; Cerone, MA; Corti, V; Fontanesi, S; Alessio, M; Bachi, A; (2005) Evaluation of the molecular mechanisms involved in the gain of function of a Li-Fraumeni TP53 mutation. Hum Mutat , 26 (2) pp. 94-103. 10.1002/humu.20192.

Cardigan, R; Lawrie, AS; Mackie, IJ; Williamson, LM; (2005) The quality of fresh-frozen plasma produced from whole blood stored at 4 degrees C overnight. TRANSFUSION , 45 (8) 1342 - 1348. 10.1111/j.1537-2995.2005.00219.x.

Carroll, VA; Nikitenko, LL; Bicknell, R; Harris, AL; (2005) Antiangiogenic activity of a domain deletion mutant of tissue plasminogen activator containing kringle 2. ARTERIOSCL THROM VAS , 25 (4) 736 - 741. 10.1161/01.ATV.0000157980.15710.2b.

Casely-Hayford, MA; Pors, K; James, CH; Patterson, LH; Hartley, JA; Searcey, M; (2005) Design and synthesis of a DNA-crosslinking azinomycin analogue. ORG BIOMOL CHEM , 3 (19) 3585 - 3589. 10.1039/b508908e.

Cerone, MA; Autexier, C; Londoño-Vallejo, JA; Bacchetti, S; (2005) A human cell line that maintains telomeres in the absence of telomerase and of key markers of ALT. Oncogene , 24 (53) pp. 7893-7901. 10.1038/sj.onc.1208934.

Cerone, MA; Ward, RJ; Londoño-Vallejo, JA; Autexier, C; (2005) Telomerase RNA mutated in autosomal dyskeratosis congenita reconstitutes a weakly active telomerase enzyme defective in telomere elongation. Cell Cycle , 4 (4) pp. 585-589.

Charrier, S; Stockholm, D; Seye, K; Opolon, P; Taveau, M; Gross, DA; Bucher-Laurent, S; (2005) A lentiviral vector encoding the human Wiskott-Aldrich syndrome protein corrects immune and cytoskeletal defects in WASP knockout mice. Gene Ther , 12 (7) pp. 597-606. 10.1038/sj.gt.3302440.

Chen-Scarabelli, C; Hughes, SE; Landon, G; Rowley, P; Allebban, Z; Lawson, N; Saravolatz, L; (2005) A case of fatal ephedra intake associated with lipofuscin accumulation, caspase activation and cleavage of myofibrillary proteins. EUR J HEART FAIL , 7 (5) 927 - 930. 10.1016/j.ejheart.2004.09.012.

Chester, KA; Baker, M; Mayer, A; (2005) Overcoming the immunologic response to foreign enzymes in cancer therapy. Expert Rev Clin Immunol , 1 (4) pp. 549-559. 10.1586/1744666X.1.4.549.

Cheung, CW; Burton, C; Smith, P; Linch, DC; Hoskin, PJ; Ardeshna, KM; (2005) Central nervous system chemoprophylaxis in non-Hodgkin lymphoma: current practice in the UK. BRIT J HAEMATOL , 131 (2) 193 - 200. 10.1111/j.1365-2141.2005.05756.x.

Cholongitas, E; Quaglia, A; Samonakis, D; Senzolo, M; Triantos, CK; Patch, D; Dhillon, AP; (2005) Transjugular liver biopsy: Is it effective for accurate histological interpretation? In: GUT. (pp. A26 - A26). B M J PUBLISHING GROUP

Clarke, DL; Belvisi, MG; Smith, SJ; Hardaker, E; Yacoub, MH; Meja, KK; Newton, R; (2005) Prostanoid receptor expression by human airway smooth muscle cells and regulation of the secretion of granulocyte colony-stimulating factor. Am J Physiol Lung Cell Mol Physiol , 288 (2) L238-L250. 10.1152/ajplung.00313.2004.

Clingen, P.H.; De Silva, I.U.; McHugh, P.J.; Ghadessy, F.J.; Tilby, M.J.; Thurston, D.E.; Hartley, J.A.; (2005) The XPF-ERCC1 endonuclease and homologous recombination contribute to the repair of minor groove DNA interstrand crosslinks inmammalian cells produced by the pyrrolo[2,1-c][1,4]benzodiazepine dimer SJG-136. Nucleic Acids Research , 33 (10) pp. 3283-3291. 10.1093/nar/gki639. Green open access
file

Clingen, P.H.; De Silva, I.U.; McHugh, P.J.; Ghadessy, F.J.; Tilby, M.J.; Thurston, D.E.; Hartley, J.A.; (2005) The XPF-ERCC1 endonuclease and homologous recombination contribute to the repair of minor groove DNA interstrand crosslinks in mammalian cells produced by the pyrrolo[2,1-c][1,4]benzodiazepine dimer SJG-136. Nucleic Acids Research , 33 (10) pp. 3283-3291. 10.1093/nar/gki639. Green open access
file

Clingen, PH; De Silva, IU; McHugh, PJ; Ghadessy, FJ; Tilby, MJ; Thurston, DE; Hartley, JA; (2005) The XPF-ERCC1 endonuclease and homologous recon bination contribute to the repair of minor groove DNA interstrand crosslinks in mammalian cells produced by the pyrrolo[2,1-c][1,4]benzodiazepine dimer SJG-136. NUCLEIC ACIDS RES , 33 (10) 3283 - 3291. 10.1093/nar/gki639. Gold open access

Coakley, M; Self, R; Marchant, W; Mackie, I; Mallett, SV; Mythen, M; (2005) Use of the platelet function analyser (PFA-100 (R)) to quantify the effect of low dose aspirin in patients with ischaemic heart disease. ANAESTHESIA , 60 (12) 1173 - 1178. 10.1111/j.1365-2044.2005.04291.x.

Cobbold, M; Khan, N; Pourgheysari, B; Tauro, S; McDonald, D; Osman, H; Assenmacher, M; (2005) Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramers. J EXP MED , 202 (3) 379 - 386. 10.1084/jem.20040613.

Cohen, H; (2005) Inherited thrombophilia and pregnancy loss-epidemiology. THROMBOSIS RESEARCH , 115 13 - 17.

Conde, L; Vaquerizas, JM; Ferrer-Costa, C; de la Cruz, X; Orozco, M; Dopazo, J; (2005) PupasView: a visual tool for selecting suitable SNPs, with putative pathological effect in genes, for genotyping purposes. Nucleic Acids Res , 33 (Web Serv) W501-W505. 10.1093/nar/gki476.

Condliffe, AM; Davidson, K; Anderson, KE; Ellson, CD; Crabbe, T; Okkenhaug, K; Vanhaesebroeck, B; (2005) Sequential activation of class IB and class IA PI3K is important for the primed respiratory burst of human but not murine neutrophils. BLOOD , 106 (4) pp. 1432-1440. 10.1182/blood-2005-03-0944.

Conti, L; Pollard, SM; Gorba, T; Reitano, E; Toselli, M; Biella, G; Sun, Y; (2005) Niche-independent symmetrical self-renewal of a mammalian tissue stem cell. PLoS Biology , 3 (9) , Article e283. 10.1371/journal.pbio.0030283. Green open access
file

Corrie, PG; Shaw, J; Spanswick, VJ; Sehmbi, R; Jonson, A; Mayer, A; Bulusu, R; (2005) Phase I trial combining gemcitabine and treosulfan in advanced cutaneous and uveal melanoma patients. BRIT J CANCER , 92 (11) 1997 - 2003. 10.1038/sj.bjc.6602586.

Corrie, PG; Shaw, J; Spanswick, VJ; Sehmbi, R; Jonson, A; Mayer, A; Bulusu, R; (2005) Phase I trial combining gemcitabine and treosulfan in advanced cutaneous and uveal melanoma patients. British Journal of Cancer , 92 (11) pp. 1997-2003.

Crawley, C; Lalancette, M; Szydlo, R; Gilleece, M; Peggs, K; Mackinnon, S; Juliusson, G; (2005) Outcomes for reduced-intensity allogeneic transplantation for multiple myeloma: an analysis of prognostic factors from the Chronic Leukaemia Working Party of the EBMT. BLOOD , 105 (11) 4532 - 4539. 10.1182/blood-2004-06-2387.

Cross, JGR; Harrison, GA; Coggill, P; Sims, S; Beck, S; Deakin, JE; Graves, JAM; (2005) Analysis of the genomic region containing the tammar wallaby (Macropus eugenii) orthologues of MHC class III genes. CYTOGENET GENOME RES , 111 (2) 110 - 117. 10.1159/000086379.

Cuomo, ME; Knebel, A; Platt, G; Morrice, N; Cohen, P; Mittnacht, S; (2005) Regulation of microfilament organization by Kaposi sarcoma-associated herpes virus-cyclin.CDK6 phosphorylation of caldesmon. J Biol Chem , 280 (43) pp. 35844-35858. 10.1074/jbc.M503877200. Gold open access

Cutillas, PR; Geering, B; Waterfield, MD; Vanhaesebroeck, B; (2005) Quantification of gel-separated proteins and their phosphorylation sites by LC-MS using unlabeled internal standards: analysis of phosphoprotein dynamics in a B cell lymphoma cell line. Mol Cell Proteomics , 4 (8) pp. 1038-1051. 10.1074/mcp.M500078-MCP200.

D

Daniell, K; Stewart, M; Madsen, E; Le, M; Handl, H; Brooks, N; Kiakos, K; (2005) Design, synthesis, and biological evaluation of achiral analogs of duocarmycin SA. Bioorg Med Chem Lett , 15 (1) pp. 177-180. 10.1016/j.bmcl.2004.10.021.

Dark, GG; Calvert, AH; Grimshaw, R; Poole, C; Swenerton, K; Kaye, S; Coleman, R; (2005) Randomized trial of two intravenous schedules of the topoisomerase I inhibitor liposomal lurtotecan in women with relapsed epithelial ovarian cancer: A trial of the National Cancer Institute of Canada Clinical Trials Group. JOURNAL OF CLINICAL ONCOLOGY , 23 (9) 1859 - 1866. 10.1200/JCO.2005.02.028.

Davidoff, AM; Gray, JT; Ng, CYC; Zhang, YB; Zhou, JF; Spence, Y; Bakar, Y; (2005) Comparison of the ability of adeno-associated viral vectors pseudotyped with serotype 2, 5, and 8 capsid proteins to mediate efficient transduction of the liver in murine and nonhuman primate models. MOL THER , 11 (6) 875 - 888. 10.1016/j.ymthe.2004.12.022.

Davidoff, AM; Ng, CYC; Zhang, YB; Streck, CJ; Mabry, SJ; Barton, SH; Baudino, T; (2005) Careful decoy receptor titering is required to inhibit tumor angiogenesis while avoiding adversely altering VEGF bioavailability. MOL THER , 11 (2) 300 - 310. 10.1016/j.ymthe.2004.09.014.

Davies, H; Hunter, C; Smith, R; Stephens, P; Greenman, C; Bignell, G; Teague, B; (2005) Somatic mutations of the protein kinase gene family in human lung cancer. CANCER RES , 65 (17) 7591 - 7595. 10.1158/0008-5472.CAN-05-1855.

Dhami, P; Coffey, AJ; Abbs, S; Vermeesch, JR; Dumanski, JP; Woodward, KJ; Andrews, RM; (2005) Exon array CGH: Detection of copy-number changes at the resolution of individual exons in the human genome. AM J HUM GENET , 76 (5) 750 - 762.

Dickson, PV; Nathwani, AC; Davidoff, AM; (2005) Delivery of antiangiogenic agents for cancer gene therapy. TECHNOL CANCER RES T , 4 (4) 331 - 341.

Dogan, A; Du, MQ; Isaacson, PG; (2005) A relapsing inflammatory syndrome and HHV-8. NEW ENGLAND JOURNAL OF MEDICINE , 353 (16) p. 1746. Green open access
file

Dotti, G; Savoldo, B; Pule, M; Straathof, KC; Biagi, E; Yvon, E; Vigouroux, S; (2005) lHuman cytotoxic T lymphocytes with reduced sensitivity to Fas-induced apoptosis. BLOOD , 105 (12) 4677 - 4684. 10.1182/blood-2004-08-3337. Green open access
file

Duarte, RF; Delgado, J; Shaw, BE; Wrench, DJ; Ethell, A; Patch, D; Dhillon, AP; (2005) Histologic features of the liver biopsy predict the clinical outcome for patients with graft-versus-host disease of the liver. BIOL BLOOD MARROW TR , 11 (10) 805 - 813. 10.1016/j.bbmt.2005.06.008.

Duarte, RF; Delgado, J; Shaw, BE; Wrench, DJ; Ethell, M; Patch, D; Dhillon, AP; (2005) Histological features in the liver biopsy predict the clinical outcome of patients with graft-versus-host disease of the liver. In: BONE MARROW TRANSPLANTATION. (pp. S43 - S43). NATURE PUBLISHING GROUP

Dudderidge, TJ; Haynes, SV; Davies, AJ; Jarmulowicz, M; Al-Akraa, MA; (2005) Vesicocervical fistula: rare complication of cesarean section demonstrated by magnetic resonance imaging. Urology , 65 (1) 174-. 10.1016/j.urology.2004.07.001.

Dudderidge, TJ; Stoeber, K; Loddo, M; Atkinson, G; Fanshawe, T; Griffiths, DF; Williams, GH; (2005) Mcm2, Geminin, and Ki67 define proliferative state and are prognostic markers in renal cell carcinoma. CLIN CANCER RES , 11 (7) 2510 - 2517.

Dudderidge, TJ; Stoeber, K; Loddo, M; Atkinson, G; Fanshawe, T; Griffiths, DF; Williams, GH; (2005) Mcm2, geminin and Ki67 define proliferative state and are predictors of outcome in renal cell carcinoma. Clinical Cancer Research , 11 pp. 2510-2517.

de Bruin, EC; van de Pas, S; Lips, EH; van Eijk, R; van der Zee, MM; Lombaerts, M; van Wezel, T; (2005) Macrodissection versus microdissection of rectal carcinoma: minor influence of stroma cells to tumor cell gene expression profiles. BMC Genomics , 6 , Article 142. 10.1186/1471-2164-6-142. Green open access
file

de Groot, NG; Garcia, CA; Verschoor, EJ; Doxiadis, GGM; Marsh, SGE; Otting, N; Bontrop, RE; (2005) Reduced MIC gene repertoire variation in west African chimpanzees as compared to humans. MOLECULAR BIOLOGY AND EVOLUTION , 22 (6) pp. 1375-1385. 10.1093/molbev/msi127.

de la Fuente, J; Richards, S; Webb, DK; Hann, IM; Mitchell, CD; Vora, AJ; Kinsey, SE; (2005) Acute lymphoblastic leukaemia has a poor outcome in children with Down syndrome due to infective death in remission - (Results of UK MRC ALL 97 trial). Blood , 106 (11) 256A-257A.

E

Edwards, C.S.; (2005) The roles of vaccinia virus proteins in kinesin-dependent microtubule transport. Doctoral thesis, University of London. Green open access
file

Eguchi, M; Eguchi-Ishimae, M; Green, A; Enver, T; Greaves, M; (2005) Directing oncogenic fusion genes into stem cells via an SCL enhancer. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA , 102 (4) pp. 1133-1138. 10.1073/pnas.0405318102.

El-Emir, E; Boxer, GM; Petrie, IA; Boden, RW; Dearling, JLJ; Begent, RHJ; Pedley, RB; (2005) Tumour parameters affected by combretastatin A-4 phosphate therapy in a human colorectal xenograft model in nude mice. EUR J CANCER , 41 (5) 799 - 806. 10.1016/j.ejca.2005.01.001.

Enver, T; Soneji, S; Joshi, C; Brown, J; Iborra, F; Orntoft, T; Thykjaer, T; (2005) Cellular differentiation hierarchies in normal and culture-adapted human embryonic stem cells. HUMAN MOLECULAR GENETICS , 14 (21) pp. 3129-3140. 10.1093/hmg/ddi345.

Enver, T; Tsuzuki, S; Brown, J; Hong, DL; Gupta, R; Ford, T; Egucchi, MI; (2005) Developmental impact of leukemic fusion genes on stem cell fate. HEMATOPOIETIC STEM CELLS V , 1044 pp. 16-23. 10.1196/annals.1349.003.

Ezoe, S; Matsumura, I; Gale, K; Satoh, Y; Ishikawa, J; Mizuki, M; Takahashi, S; (2005) GATA transcription factors inhibit cytokine-dependent growth and survival of a hematopoietic cell line through the inhibition of STAT3 activity. JOURNAL OF BIOLOGICAL CHEMISTRY , 280 (13) pp. 13163-13170. 10.1074/jbc.M413461200. Gold open access

F

Fielding, AK; (2005) Measles as a potential oncolytic virus. REV MED VIROL , 15 (2) 135 - 142. 10.1002/rmv.455.

Fitzmaurice, DA; Gardiner, C; Kitchen, S; Mackie, I; Murray, ET; Machin, SJ; Brit Soc Haematology Taskforce Hae, ; (2005) An evidence-based review and guidelines for patient self-testing and management of oral anticoagulation. BRIT J HAEMATOL , 131 (2) 156 - 165. 10.1111/j.1365-2141.2005.05739.x.

Fleenor, D; Oden, J; Kelly, PA; Mohan, S; Alliouachene, S; Pende, M; Wentz, S; (2005) Roles of the lactogens and somatogens in perinatal and postnatal metabolism and growth: studies of a novel mouse model combining lactogen resistance and growth hormone deficiency. Endocrinology , 146 (1) pp. 103-112. 10.1210/en.2004-0744.

Foroni, L; Mitchell, W; Rai, LJ; Casanova, A; Gerrard, G; Patel, B; Richards, S; (2005) Molecular monitoring of residual disease (MRD) during induction and intensification phases in low risk adult B cell ALL treated according to the MRC UKALL12 protocol. In: BLOOD. (pp. 423A - 423A). AMER SOC HEMATOLOGY

Foroni, L; Mitchell, W; Rai, LJ; Casanova, A; Patel, B; Richards, S; Fielding, A; (2005) Value of molecular monitoring for minimal residual disease preceding autologous SCT following diagnosis of B cell acute lymphoblastic leukemia in patients treated with the MRC UKALL12 protocol. In: BLOOD. (pp. 423A - 424A). AMER SOC HEMATOLOGY

Forshew, T; Johnson, CA; Khaliq, S; Pasha, S; Willis, C; Abbasi, R; Tee, L; (2005) Locus heterogeneity in autosomal recessive congenital cataracts: linkage to 9q and germline HSF4 mutations. HUM GENET , 117 (5) 452 - 459. 10.1007/s00439-005-1309-9.

Forshew, T; Khaliq, S; Tee, L; Smith, U; Johnson, CA; Mehdi, SQ; Maher, ER; (2005) Identification of novel TYR and TYRP1 mutations in oculocutaneous albinism. Clin Genet , 68 (2) pp. 182-184. 10.1111/j.1399-0004.2005.00460.x.

Freeman, L; Hewison, M; Hughes, SV; Evans, KN; Hardie, D; Means, TK; Chakraverty, R; (2005) Expression of 11 beta-hydroxysteroid dehydrogenase type 1 permits regulation of glucocorticoid bioavailability by human dendritic cells. BLOOD , 106 (6) 2042 - 2049. 10.1182/blood-2005-01-0186.

G

Gale, RE; Hills, R; Kottaridis, PD; Srirangan, S; Wheatley, K; Burnett, AK; Linch, DC; (2005) No evidence that FLT3 status should be considered as an indicator for transplantation in acute myeloid leukemia (AML): an analysis of 1135 patients, excluding acute promyelocytic leukemia, from the UK MRC AML 10 and 12 trials. BLOOD , 106 (10) 3658 - 3665. 10.1182/blood-2005-03-1323. Green open access
file

Gale, RE; Hills, R; Pizzey, AR; Kottaridis, PD; Swirsky, D; Gilkes, AF; Nugent, E; (2005) Relationship between FLT3 mutation status, biologic characteristics, and response to targeted therapy in acute promyelocytic leukemia. BLOOD , 106 (12) 3768 - 3776. Green open access
file

Galluzzi, L; Pinti, M; Guaraldi, G; Mussini, C; Troiano, L; Roat, E; Giovenzana, C; (2005) Altered mitochondrial RNA production in adipocytes from HIV-infected individuals with lipodystrophy. Antivir Ther , 10 Sup M91-M99.

Galluzzi, L; Pinti, M; Troiano, L; Prada, N; Nasi, M; Ferraresi, R; Salomoni, P; (2005) Changes in mitochondrial RNA production in cells treated with nucleoside analogues. ANTIVIR THER , 10 (1) 191 - 195.

Gardiner, C; Pennaneac'h, C; Walford, C; Machin, SJ; Mackie, IJ; (2005) An evaluation of rapid D-dimer assays for the exclusion of deep vein thrombosis. BRIT J HAEMATOL , 128 (6) 842 - 848. 10.1111/j.1365-2141.2005.05394.x.

Gardiner, C; Williams, K; Mackie, IJ; Machin, SJ; Cohen, H; (2005) Patient self-testing is a reliable and acceptable alternative to laboratory INR monitoring. BRIT J HAEMATOL , 128 (2) 242 - 247. 10.1111/j.1365.2141.2004.05300.x.

Gardiner, C; Williams, K; Mackie, IJ; Machin, SJ; Cohen, H; (2005) Patient self-testing is a reliable and acceptable alternative to laboratory INR monitoring. Br J Haematol , 128 (2) pp. 242-247. 10.1111/j.1365-2141.2004.05300.x.

Gerrard, G; Butters, TD; Ganeshaguru, K; Mehta, A; (2005) Glucosylceramide synthase inhibitors sensitise CLL cells to cytotoxic agents without reversing P-gp functional activity. European Journal of Pharmacology , 609 (1-3) pp. 34-39.

Gibbs, DD; Theti, DS; Wood, N; Green, M; Raynaud, F; Valenti, M; Forster, MD; (2005) BGC 945, a novel tumor-selective thymidylate synthase inhibitor targeted to alpha-folate receptor-overexpressing tumors. Cancer Res , 65 (24) pp. 11721-11728. 10.1158/0008-5472.CAN-05-2034.

Godfrey, A; Anderson, J; Papanastasiou, A; Takeuchi, Y; Boshoff, C; (2005) Inhibiting primary effusion lymphoma, by lentiviral vectors encoding short hairpin RNA. BLOOD , 105 (6) 2510 - 2518. 10.1182/blood-2004-08-3052.

Gomez, K; McVey, JH; Tuddenham, E; (2005) Inhibition of coagulation by macromolecular complexes. Haematologica , 90 (11) pp. 1570-1576. Gold open access

Gomez-Escobar, N; Bennett, C; Prieto-Lafuente, L; Aebischer, T; Blackburn, CC; Maizels, RM; (2005) Heterologous expression of the filarial nematode alt gene products reveals their potential to inhibit immune function. BMC Biology , 3 , Article 108. 10.1186/1741-7007-3-8. Green open access
file

Gondek, DC; Lu, LF; Quezada, SA; Sakaguchi, S; Noelle, RJ; (2005) Cutting edge: Contact-mediated suppression by CD4(+)-CD25(+) regulatory cells involves a granzyme B-dependent, perforin-independent mechanism. J IMMUNOL , 174 (4) 1783 - 1786.

Grandage, VL; Gale, RE; Lich, DC; Khwaja, A; (2005) PI3-kinase/Akt is constitutively active in primary acute myeloid leukaemia cells and regulates survival and chemoresistance via NF-κB, MAPkinase and p53 pathways. Leukemia , 19 (4) pp. 586-594. 10.1038/sj.leu.2403653.

Grandage, VL; Gale, RE; Linch, DC; Khwaja, A; (2005) PI3-kinase/Akt is constitutively active in primary acute myeloid leukaemia cells and regulates survival and chemoresistance via NF-kappa B, MAPkinase and p53 pathways. LEUKEMIA , 19 (4) 586 - 594. 10.1038/sj.leu.2403653.

Gregg, R; Smith, CM; Clark, FJ; Dunnion, D; Khan, N; Chakraverty, R; Nayak, L; (2005) The number of human peripheral blood CD4(+) CD25(high) regulatory T cells increases with age. CLIN EXP IMMUNOL , 140 (3) 540 - 546. 10.1111/j.1365-2249.2005.02798.x.

Guenther, MG; Jenner, RG; Chevalier, B; Nakamura, T; Croce, CM; Canaani, E; Young, RA; (2005) Global and Hox-specific roles for the MLL1 methyltransferase. Proc Natl Acad Sci U S A , 102 (24) pp. 8603-8608. 10.1073/pnas.0503072102.

Guest, RD; Hawkins, RE; Kirillova, N; Cheadle, EJ; Arnold, J; O'Neill, A; Irlam, J; (2005) The role of extracellular spacer regions in the optimal design of chimeric immune receptors - Evaluation of four different scFvs and antigens. J IMMUNOTHER , 28 (3) 203 - 211.

Guérardel, A; Barat-Houari, M; Vasseur, F; Dina, C; Vatin, V; Clément, K; Eberlé, D; (2005) Analysis of sequence variability in the CART gene in relation to obesity in a Caucasian population. BMC Genet , 6 19-. 10.1186/1471-2156-6-19. Gold open access

H

Hardcastle, IR; Ahmed, SU; Atkins, H; Calvert, AH; Curtin, NJ; Farnie, G; Golding, BT; (2005) Isoindolinone-based inhibitors of the MDM2-p53 protein-protein interaction. BIOORG MED CHEM LETT , 15 (5) 1515 - 1520. 10.1016/j.bmcl.2004.12.061.

Harish, S; Saifuddin, A; Cannon, SR; Flanagan, AM; (2005) Synovial chondromastosis of the foot presenting with Lisfranc dislocation. Skeletal Radiology , 1 10.1007/s00256-005-0923-x.

Harney, J.A.; (2005) An investigation of low dose hyper-radiosensitivity - Does it have a role clinically? Doctoral thesis, University of London. Green open access
file

Harrison, P; Mackie, I; Mathur, A; Robinson, MSC; Hong, Y; Erusalimsky, JD; Machin, SJ; (2005) Platelet hyper-function in acute coronary syndromes. BLOOD COAGUL FIBRIN , 16 (8) 557 - 562.

Hart, DP; Avivi, I; Thomson, KJ; Peggs, KS; Morris, EC; Goldstone, AH; Linch, DC; (2005) Use of F-18-FDG positron emission tomography following allogeneic transplantation to guide adoptive immunotherapy with donor lymphocyte infusions. BRIT J HAEMATOL , 128 (6) 824 - 829. 10.1111/j.1365-2141.2005.05388.x.

Hartmann, G; Vassileva, V; Piquette-Miller, M; (2005) Impact of endotoxin-induced changes in P-glycoprotein expression on disposition of doxorubicin in mice. DRUG METABOLISM AND DISPOSITION , 33 (6) pp. 820-828. 10.1124/dmd.104.002568.

Henderson, SR; Guiliano, D; Presneau, N; McLean, S; Frow, R; Vujovic, S; Anderson, J; (2005) A molecular map of mesenchymal tumors. GENOME BIOL , 6 (9) , Article R76. 10.1186/gb-2005-6-9-r76. Green open access
file

Hergovich, A; Bichsel, SJ; Hemmings, BA; (2005) Human NDR kinases are rapidly activated by MOB proteins through recruitment to the plasma membrane and phosphorylation. MOL CELL BIOL , 25 (18) 8259 - 8272. 10.1128/MCB.25.18.8259-8272.2005.

Hing, KA; Annaz, B; Saeed, S; Revell, PA; Buckland, T; (2005) Microporosity enhances bioactivity of synthetic bone graft substitutes. J Mater Sci Mater Med , 16 (5) pp. 467-475. 10.1007/s10856-005-6988-1.

Hirschfield, GM; Gallimore, JR; Kahan, MC; Hutchinson, WL; Sabin, CA; Benson, GM; Dhillon, AP; (2005) Transgenic human C-reactive protein is not proatherogenic in apolipoprotein E-deficient mice. P NATL ACAD SCI USA , 102 (23) 8309 - 8314. 10.1073/pnas.0503202102.

Ho, EA; Vassileva, V; Allen, C; Piquette-Miller, M; (2005) In vitro and in vivo characterization of a novel biocompatible polymer-lipid implant system for the sustained delivery of paclitaxel. JOURNAL OF CONTROLLED RELEASE , 104 (1) pp. 181-191. 10.1016/j.jconrel.2005.02.008.

Hoskin, PJ; Rojas, AM; Phillips, H; Saunders, MI; (2005) Acute and late morbidity in the treatment of advanced bladder carcinoma with accelerated radiotherapy, carbogen, and nicotinamide. Cancer , 103 (11) pp. 2287-2297. 10.1002/cncr.21048.

Hoskin, PJ; Smith, P; Maughan, TS; Gilson, D; Vernon, C; Syndikus, I; Linch, DC; (2005) Long-term results of a randomised trial of involved field radiotherapy vs extended field radiotherapy in stage I and II Hodgkin lymphoma. CLIN ONCOL-UK , 17 (1) 47 - 53. 10.1016/j.clon.2004.07.004.

Howie, AJ; Pankhurst, T; Sarioglu, S; Turhan, N; Adu, D; (2005) Evolution of nephrotic-associated focal segmental glomerulosclerosis and relation to the glomerular tip lesion. KIDNEY INTERNATIONAL , 67 (3) pp. 987-1001. 10.1111/j.1523-1755.2005.00162.x.

Hubbard, T; Andrews, D; Caccamo, M; Cameron, G; Chen, Y; Clamp, M; Clarke, L; (2005) Ensembl 2005. Nucleic Acids Res , 33 (Database) D447-D453. 10.1093/nar/gki138.

Hughes, DA; Mehta, AB; (2005) Vascular complications of Fabry disease: enzyme replacement and other therapies. Acta Paediatr Suppl , 94 (447) pp. 28-33.

Hughes, SE; McKenna, WJ; (2005) New insights into the pathology of inherited cardiomyopathy. HEART , 91 (2) 257 - 264. 10.1136/hrt.2004.040337. Gold open access

Hunter, HM; Peggs, K; Powles, R; Rahemtulla, A; Mahendra, P; Cavenagh, J; Littlewood, T; (2005) Analysis of outcome following allogeneic haemopoietic stem cell transplantation for myeloma using myeloablative conditioning - evidence for a superior outcome using melphalan combined with total body irradiation. BRIT J HAEMATOL , 128 (4) 496 - 502. 10.1111/j.1365-2141.2004.05330.x.

I

Ishiko, E; Matsumura, I; Ezoe, S; Gale, K; Ishiko, J; Satoh, Y; Tanaka, H; (2005) Notch signals inhibit the development of erythroid/megakaryocytic cells by suppressing GATA-1 activity through the induction of HES1. JOURNAL OF BIOLOGICAL CHEMISTRY , 280 (6) pp. 4929-4939. 10.1074/jbc.M406788200. Gold open access

J

Jacobs, EMG; Hendriks, JCM; van Tits, BLJH; Evans, PJ; Breuer, W; Liu, DY; Jansen, EHJM; (2005) Results of an international round robin for the quantification of serum non-transferrin-bound iron: Need for defining standardization and a clinically relevant isoform. ANAL BIOCHEM , 341 (2) 241 - 250. 10.1016/j.ab.2005.03.008.

Jadeja, S; Smyth, I; Pitera, JE; Taylor, MS; van Haelst, M; Bentley, E; McGregor, L; (2005) Identification of a new gene mutated in Fraser syndrome and mouse myelencephalic blebs. NAT GENET , 37 (5) 520 - 525. 10.1038/ng1549.

Jalal, H; Bibby, DF; Tang, JW; Bennett, J; Kyriakou, C; Peggs, K; Cubitt, D; (2005) First reported outbreak of diarrhea due to adenovirus infection in a hematology unit for adults. J CLIN MICROBIOL , 43 (6) 2575 - 2580. 10.1128/JCM.43.6.2575-2580.2005.

Jenner, RG; Young, RA; (2005) Insights into host responses against pathogens from transcriptional profiling. Nat Rev Microbiol , 3 (4) pp. 281-294. 10.1038/nrmicro1126.

Jenny, C; Toublanc, E; Danos, O; Merten, OW; (2005) Evaluation of a Serum-free Medium for the Production of rAAV-2 using HeLa Derived Producer Cells. Cytotechnology , 49 (1) pp. 11-23. 10.1007/s10616-005-5361-z.

K

Kalra, D; Singleton, P; Milan, J; MacKay, J; Detmer, D; Rector, A; Ingram, D; (2005) Security and confidentiality approach for the clinical E-Science framework (CLEF). METHODS OF INFORMATION IN MEDICINE , 44 (2) 193 - 197.

Ke, XY; Miretti, MM; Broxholme, J; Hunt, S; Beck, S; Bentley, DR; Deloukas, P; (2005) A comparison of tagging methods and their tagging space. HUM MOL GENET , 14 (18) 2757 - 2767. 10.1093/hmg/ddi309.

Kendall, AH; Williams, GH; Stoeber, K; Salter, J; Dowsett, M; (2005) Effect of estrogen deprivation on proliferation marker Ki-67 and minichromosome maintenance protein-2 (Mcm-2) in normal postmenopausal breast tissue: potential biomarkers for chemoprevention. In: BREAST CANCER RESEARCH AND TREATMENT. (pp. S172 - S172). SPRINGER

Kenny, PA; Enver, T; Ashworth, A; (2005) Receptor and secreted targets of Wnt-I/beta-catenin signalling in mouse mammary epithelial cells. BMC Cancer , 5 , Article 3. 10.1186/1471-2407-5-3. Green open access
file

Khelifi, AF; D'Alcontres, MS; Salomoni, P; (2005) Daxx is required for stress-induced cell death and JNK activation. CELL DEATH DIFFER , 12 (7) 724 - 733. 10.1038/sj.cdd.4401559.

Kim, JB; Stein, R; O'Hare, MJ; (2005) Tumour-stromal interactions in breast cancer: the role of stroma in tumourigenesis. Tumour Biol , 26 (4) pp. 173-185. 10.1159/000086950.

Kim, JB; Stein, RC; O'Hare, MJ; (2005) Development of a fully "humanized" xenograft model of breast cancer - New ideas for the development of pre-clinical prevention models. International Journal of Cancer Prevention , 2 (2) pp. 87-107.

Kindle, KB; Troke, PJF; Collins, HM; Matsuda, S; Bossi, D; Bellodi, C; Kalkhoven, E; (2005) MOZ-TIF2 inhibits transcription by nuclear receptors and p53 by impairment of CBP function. MOL CELL BIOL , 25 (3) 988 - 1002. 10.1128/MCB.25.3.988-1002.2005.

King-Underwood, L; Little, S; Baker, M; Clutterbuck, R; Delassus, S; Enver, T; Lebozer, C; (2005) Wt1 is not essential for hematopoiesis in the mouse. LEUKEMIA RES , 29 (7) 803 - 812. 10.1016/j.leukres.2004.11.020.

Kingsbury, SR; Loddo, M; Fanshawe, T; Obermann, EC; Prevost, AT; Stoeber, K; Williams, GH; (2005) Repression of DNA replication licensing in quiescence is independent of geminin and may define the cell cycle state of progenitor cells. EXP CELL RES , 309 (1) 56 - 67. 10.1016/j.yexcr.2005.05.027.

Knock, J; Shah, M; Wyatt, J; Dixon, M; Casali, G; Lewis, F; Martin, I; (2005) MCM proteins and geminin in gastric cancer: Association with prognosis, histological type, DNA ploidy and proliferation. In: JOURNAL OF PATHOLOGY. (pp. 8 - 8). JOHN WILEY & SONS LTD

Knoll, N; Ruhe, C; Veeriah, S; Sauer, J; Glei, M; Gallagher, EP; Pool-Zobel, BL; (2005) Genotoxicity of 4-hydroxy-2-nonenal in human colon tumor cells is associated with cellular levels of glutathione and the modulation of glutathione S-transferase A4 expression by butyrate. Toxicol Sci , 86 (1) pp. 27-35. 10.1093/toxsci/kfi171.

Kocjan, G; (2005) Cytological and molecular diagnosis of lymphoma. J CLIN PATHOL , 58 (6) 561 - 567. 10.1136/jcp.2004.019133.

Kocjan, G; Priollet, BC; Desai, M; Koutselini, H; Mahovlic, V; Oliveira, MH; Pohar-Marinsek, Z; (2005) BSCC, Bethesda or other? Terminology in cervical cytology European panel discussion. CYTOPATHOLOGY , 16 (3) 113 - 119.

Koonrugsa, N.; (2005) The role of fission yeast microtubule associated protein, Alp14, in microtubule stabilisation and spindle assembly checkpoint maintenance. Doctoral thesis, University of London. Green open access
file

Kostoula, V; Khan, K; Savage, K; Stubbs, M; Quaglia, A; Dhillon, AP; Hochhauser, D; (2005) Expression of c-kit (CD117) in neuroendocrine tumours - A target for therapy? ONCOL REP , 13 (4) 643 - 647.

Kristeleit, R; Fong, P; Aherne, GW; de Bono, J; (2005) Histone deacetylase inhibitors: emerging anticancer therapeutic agents? Clin Lung Cancer , 7 Supp S19-S30.

Kroger, N; Shaw, B; Iacobelli, S; Zabelina, T; Peggs, K; Shimoni, A; Nagler, A; (2005) Comparison between antithymocyte globulin and alemtuzumab and the possible impact of KIR-ligand mismatch after dose-reduced conditioning and unrelated stem cell transplantation in patients with multiple myeloma. BRIT J HAEMATOL , 129 (5) 631 - 643. 10.1111/j.1365-2141.2005.05513.x.

Krützfeldt, M; Ellis, M; Weekes, DB; Bull, JJ; Eilers, M; Vivanco, MD; Sellers, WR; (2005) Selective ablation of retinoblastoma protein function by the RET finger protein. Mol Cell , 18 (2) pp. 213-224. 10.1016/j.molcel.2005.03.009.

Kulkarni, S; Davies, AJW; Treurnicht, K; Dudderidge, TJ; Al-Akraa, M; (2005) Misplaced Macroplastique injection presenting as a vaginal nodule and a bladder mass. INT J CLIN PRACT , 59 85 - 86.

Kyriakou, C; Thomson, K; D'Sa, S; Flory, A; Hanslip, J; Goldstone, AH; Yong, KL; (2005) Low-dose thalidomide in combination with oral weekly cyclophosphamide and pulsed dexamethasone is a well tolerated and effective regimen in patients with relapsed and refractory multiple myeloma. BRIT J HAEMATOL , 129 (6) 763 - 770. 10.1111/j.1365-2141.2005.05521.x.

L

Lagos, D; Bourboulia, D; Vart, R; Trotter, M; Malcles, M; Wang, HW; Boshoff, C; (2005) Kaposi sarcoma herpesvirus: Update. RETROVIROLOGY , 2 , Article S40. 10.1186/1742-4690-2-S1-S40. Gold open access

Laman, H; Funes, JM; Ye, H; Henderson, S; Galinanes-Garcia, L; Hara, E; Knowles, P; (2005) Transforming activity of Fbxo7 is mediated specifically through regulation of cyclin D/cdk6. The EMBO journal , 24 (17) pp. 3104-3116.

Laman, H; Funes, JM; Ye, HT; Henderson, S; Galinanes-Garcia, L; Hara, E; Knowles, P; (2005) Transforming activity of Fbxo7 is mediated specifically through regulation of cyclin D/cdk6. EMBO J , 24 (17) 3104 - 3116. 10.1038/sj.emboj.7600775.

Laurence, AD; Peggs, KS; (2005) Cerebral and pulmonary nocardia in a bone marrow transplant patient. Br J Haematol , 129 (6) 711-. 10.1111/j.1365-2141.2005.05474.x.

Lawrence, T; Puel, A; Reichenbach, J; Ku, CL; Chapgier, A; Renner, E; Minard-Colin, V; (2005) Autosomal-dominant primary immunodeficiencies. Curr Opin Hematol , 12 (1) pp. 22-30.

LePla, RC; Landreau, CAS; Shipman, M; Hartley, JA; Jones, GDD; (2005) Azinomycin inspired bisepoxides: influence of linker structure on in vitro cytotoxicity and DNA interstrand cross-linking. BIOORG MED CHEM LETT , 15 (11) 2861 - 2864. 10.1016/j.bcml.2005.03.091.

Lee, M; Mahroof, S; Pringle, J; Short, SC; Briggs, TWR; Cannon, SR; (2005) Diffuse pigmented villonodular synovitis of the foot and ankle treated with surgery and radiotherapy. INTERNATIONAL ORTHOPAEDICS , 29 (6) pp. 403-405. 10.1007/s00264-005-0004-8.

Little, AM; Marsh, SGE; Madrigal, JA; (2005) Histocompatibilty. In: Postgraduate Haematology. (pp. 395-418). Blackwell Publishing: Oxford.

Lo, S; Tolner, B; Taanman, JW; Cooper, JM; Gu, M; Hartley, JA; Schapira, AHV; (2005) Assessment of the significance of mitochondrial DNA damage by chemotherapeutic agents. INT J ONCOL , 27 (2) 337 - 344.

Lobo, VJSA; Luquero, CIA; Alvarez-Vallina, L; Tipping, AJ; Viniegra, JG; Losa, JH; Cobo, CP; (2005) Modulation of the p38 MAR (mitogen-activated protein kinase) pathway through Bcr/Abl: implications in the cellular response to Ara-C. BIOCHEM J , 387 231 - 238. 10.1042/BJ20040927.

M

Macrae, M; Neve, RM; Rodriguez-Viciana, P; Haqq, C; Yeh, J; Chen, CR; Gray, JW; (2005) A conditional feedback loop regulates Ras activity through EphA2. CANCER CELL , 8 (2) 111 - 118. 10.1016/j.ccr.2005.07.005.

Malone, FD; Canick, JA; Ball, RH; Nyberg, DA; Comstock, CH; Bukowski, R; Berkowitz, RL; (2005) First-trimester or second-trimester screening, or both, for Down's syndrome. NEW ENGL J MED , 353 (19) 2001 - 2011. Green open access
file

Manoussaka, MS; Memon, A; Nathwani, A; Porakishvili, N; Clark, E; Lydyard, PM; (2005) Toll like receptors (TLRs) in B cell chronic lymphocytic leukemia (B-CLL). In: BLOOD. (pp. 326B - 326B). AMER SOC HEMATOLOGY

Mansour, MR; Dogan, A; Morris, EC; Khwaja, A; Linch, DC; Mackinnon, S; Peggs, KS; (2005) Allogeneic transplantation for hepatosplenic alpha beta T-cell lymphoma. BONE MARROW TRANSPL , 35 (9) 931 - 934. 10.1038/sj.bmt.1704897.

Mansouri, D; Adimi, P; Mirsaeidi, M; Mansouri, N; Khalilzadeh, S; Masjedi, MR; Adimi, P; (2005) Inherited disorders of the IL-12-IFN-gamma axis in patients with disseminated BCG infection. Eur J Pediatr , 164 (12) pp. 753-757. 10.1007/s00431-005-1689-9.

Marafioti, T; Pozzobon, M; Hansmann, ML; Gaulard, P; Barth, TF; Copie-Bergman, C; Roberton, H; (2005) Expression pattern of intracellular leukocyte-associated proteins in primary mediastinal B cell lymphoma. Leukemia , 19 (5) pp. 856-861. 10.1038/sj.leu.2403702.

Marafioti, T; Pozzobon, M; Hansmann, ML; Ventura, R; Pileri, SA; Roberton, H; Gesk, S; (2005) The NFATc1 transcription factor is widely expressed in white cells and translocates from the cytoplasm to the nucleus in a subset of human lymphomas. Br J Haematol , 128 (3) pp. 333-342. 10.1111/j.1365-2141.2004.05313.x.

Marie-Egyptienne, DT; Cerone, MA; Londoño-Vallejo, JA; Autexier, C; (2005) A human-Tetrahymena pseudoknot chimeric telomerase RNA reconstitutes a nonprocessive enzyme in vitro that is defective in telomere elongation. Nucleic Acids Res , 33 (17) pp. 5446-5457. 10.1093/nar/gki848.

Marks, AJ; Cooper, MS; Anderson, RJ; Orchard, KH; Hale, G; North, JM; Ganeshaguru, K; (2005) Selective apoptotic killing of malignant hemopoietic cells by anti body-targeted delivery of an amphipathic peptide. CANCER RES , 65 (6) 2373 - 2377.

Marsh, SG; (2005) Nomenclature for factors of the HLA system, update August 2005. Int J Immunogenet , 32 (6) pp. 429-430. 10.1111/j.1744-313X.2005.00555.x.

Marsh, SG; (2005) Nomenclature for factors of the HLA system, update February 2005. Int J Immunogenet , 32 (3) 215-. 10.1111/j.1744-313X.2005.00518.x.

Marsh, SG; (2005) Nomenclature for factors of the HLA system, update January 2005. Int J Immunogenet , 32 (3) pp. 213-214. 10.1111/j.1744-313X.2005.00517.x.

Marsh, SG; (2005) Nomenclature for factors of the HLA system, update March 2005. Int J Immunogenet , 32 (3) pp. 217-218. 10.1111/j.1744-313X.2005.00520.x.

Marsh, SG; (2005) Nomenclature for factors of the HLA system, update October 2004. Int J Immunogenet , 32 (1) 71-. 10.1111/j.1744-313X.2005.00492.x.

Marsh, SG; (2005) Nomenclature for factors of the HLA system, update September 2005. Int J Immunogenet , 32 (6) pp. 431-432. 10.1111/j.1744-313X.2005.00556.x.

Marsh, SG; (2005) Nomenclature for factors of the HLA system, updated July 2005. Int J Immunogenet , 32 (6) pp. 425-428. 10.1111/j.1744-313X.2005.00544.x.

Marsh, SG; WHO Nomenclature Committee, ; (2005) Nomenclature for factors of the HLA system, update August 2004. Hum Immunol , 66 (1) 92-. 10.1016/j.humimm.2004.10.011.

Marsh, SG; WHO Nomenclature Committee, ; (2005) Nomenclature for factors of the HLA system, update September 2004. Hum Immunol , 66 (1) 93-. 10.1016/j.humimm.2004.10.012.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2005) Nomenclature for factors of the HLA System, update December 2004. Hum Immunol , 66 (3) pp. 329-330. 10.1016/j.humimm.2005.01.016.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2005) Nomenclature for factors of the HLA System, update November 2004. Hum Immunol , 66 (3) 328-. 10.1016/j.humimm.2005.01.015.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2005) Nomenclature for factors of the HLA System, update October 2004. Hum Immunol , 66 (3) pp. 326-327. 10.1016/j.humimm.2005.01.014.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2005) Nomenclature for factors of the HLA system, update April 2005. Int J Immunogenet , 32 (5) pp. 325-326. 10.1111/j.1744-313X.2005.00527.x.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2005) Nomenclature for factors of the HLA system, update April 2005. Hum Immunol , 66 (9) pp. 1019-1021. 10.1016/j.humimm.2005.10.003.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2005) Nomenclature for factors of the HLA system, update December 2004. Tissue Antigens , 65 (3) pp. 299-300. 10.1111/j.1399-0039.2005.00377.x.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2005) Nomenclature for factors of the HLA system, update February 2005. Hum Immunol , 66 (9) pp. 1015-1016. 10.1016/j.humimm.2005.10.013.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2005) Nomenclature for factors of the HLA system, update January 2005. Hum Immunol , 66 (9) pp. 1013-1014. 10.1016/j.humimm.2005.10.012.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2005) Nomenclature for factors of the HLA system, update July 2005. Hum Immunol , 66 (11) pp. 1183-1186. 10.1016/j.humimm.2005.10.006.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2005) Nomenclature for factors of the HLA system, update June 2005*. Int J Immunogenet , 32 (5) pp. 329-331. 10.1111/j.1744-313X.2005.00535.x.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2005) Nomenclature for factors of the HLA system, update June 2005. Hum Immunol , 66 (9) pp. 1025-1027. 10.1016/j.humimm.2005.10.005.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2005) Nomenclature for factors of the HLA system, update March 2005. Hum Immunol , 66 (9) pp. 1017-1018. 10.1016/j.humimm.2005.10.014.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2005) Nomenclature for factors of the HLA system, update May 2005*. Int J Immunogenet , 32 (5) pp. 327-328. 10.1111/j.1744-313X.2005.00531.x.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2005) Nomenclature for factors of the HLA system, update May 2005. Hum Immunol , 66 (9) pp. 1022-1024. 10.1016/j.humimm.2005.10.004.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2005) Nomenclature for factors of the HLA system, update November 2004. Tissue Antigens , 65 (2) pp. 208-209. 10.1111/j.1399-0039.2005.00366.x.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2005) Nomenclature for factors of the HLA system, update October 2004. Tissue Antigens , 65 (2) pp. 206-207. 10.1111/j.1399-0039.2005.00357.x.

Marsh, SGE; (2005) Nomenclature for factors of the HLA system, update June 2005. TISSUE ANTIGENS , 66 (4) pp. 338-340. 10.1111/j.1399-0039.2005.00479.x.

Marsh, SGE; Albert, ED; Bodmer, WF; Bontrop, RE; Dupont, B; Erlich, HA; Geraghty, DE; (2005) Nomenclature for factors of the HLA system, 2004. TISSUE ANTIGENS , 65 (4) pp. 301-369. 10.1111/j.1399-0039.2005.00379.x.

Marsh, SGE; Albert, ED; Bodmer, WF; Bontrop, RE; Dupont, B; Erlich, HA; Geraghty, DE; (2005) Nomenclature for factors of the HLA system, 2004. HUMAN IMMUNOLOGY , 66 (5) pp. 571-636. 10.1016/j.humimm.2005.02.002.

Martin, C; Ellis, T; McGurk, CJ; Jenkins, TC; Hartley, JA; Waring, MJ; Thurston, DE; (2005) Sequence-selective interaction of the minor-groove interstrand cross-linking agent SJG-136 with naked and cellular DNA: Footprinting and enzyme inhibition studies. BIOCHEMISTRY-US , 44 (11) 4135 - 4147. 10.1021/bi0479813.

Mauri, P; Scarpa, A; Nascimbeni, AC; Benazzi, L; Parmagnani, E; Mafficini, A; Della Peruta, M; (2005) Identification of proteins released by pancreatic cancer cells by multidimensional protein identification technology: a strategy for identification of novel cancer markers. FASEB J , 19 (7) 1125 - +. 10.1096/fj.04-3000fje.

Mawdsley, S.K.V.; (2005) The prognostic and therapeutic significance of biological molecular markers in human anorectal carcinomas treated with 5'fluorouracil chemoradiation. Doctoral thesis, University of London. Green open access
file

Mayor, NP; Cox, ST; McWhinnie, AJ; Argüello, JR; Shaw, BE; Little, AM; Madrigal, JA; (2005) Sequence of a novel HLA-A*0301 intronic variant (A*03010103). Tissue Antigens , 65 (1) pp. 107-109. 10.1111/j.1399-0039.2005.00340.x.

McCabe, DJH; Harrison, P; Mackie, IJ; Sidhu, PS; Lawrie, AS; Purdy, G; Machin, SJ; (2005) Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA. PLATELETS , 16 (5) 269 - 280. 10.1080/09537100400020567.

McCabe, DJH; Harrison, P; Mackie, IJ; Sidhu, PS; Lawrie, AS; Watt, H; Machin, SJ; (2005) Increased platelet count and leucocyte-platelet complex formation in acute symptomatic compared with asymptomatic severe carotid stenosis. J NEUROL NEUROSUR PS , 76 (9) 1249 - 1254. 10.1136/jnnp.2004.051003. Gold open access

McLean, SR; Gana-Weisz, M; Hartzoulakis, B; Frow, R; Whelan, J; Selwood, D; Boshoff, C; (2005) Imatinib binding and cKIT inhibition is abrogated by the cKIT kinase domain I missense mutation Val(654)Ala. MOL CANCER THER , 4 (12) 2008 - 2015. 10.1158/1535-7163.MCT-05-0070.

McMahon, K; Hadjur, S; Menzel, U; Kioussis, D; Brady, HJM; (2005) Elucidating the role of MLL in adult murine haematopoiesis. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 10 - 10). BLACKWELL PUBLISHING

Mehta, A; Ginsberg, L; FOS Investigators, ; (2005) Natural history of the cerebrovascular complications of Fabry disease. ACTA PAEDIATRICA , 94 24 - 27. 10.1080/08035320510028076.

Miller, RF; Scully, M; Cohen, H; Roedling, S; Starke, R; Edwards, SG; Machin, SJ; (2005) Thrombotic thrombocytopaenic purpura in HIV-infected patients. INT J STD AIDS , 16 (8) 538 - 542.

Miretti, MM; Walsh, EC; Ke, XY; Delgado, M; Griffiths, M; Hunt, S; Morrison, J; (2005) A high-resolution linkage-disequilibrium map of the human major histocompatibility complex and first generation of tag single-nucleotide polymorphisms. AM J HUM GENET , 76 (4) 634 - 646.

Mittnacht, S; (2005) The retinoblastoma protein--from bench to bedside. Eur J Cell Biol , 84 (2-3) pp. 97-107. 10.1016/j.ejcb.2004.12.012.

Morris, E; Mackinnon, S; (2005) Outcome following alemtuzumab (CAMPATH-1H)-containing reduced intensity allogeneic transplant regimen for relapsed and refractory non-Hodgkin's lymphoma (NHL). TRANSFUSION AND APHERESIS SCIENCE , 32 (1) 73 - 83. 10.1016/j.transci.2004.10.008.

Morris, EC; Mackinnon, S; (2005) Reduced intensity allogeneic stem cell transplantation for low grade non-Hodgkin's lymphoma. BEST PRACT RES CL HA , 18 (1) 129 - 142. 10.1016/j.beha.2004.08.015.

Mulholland, PJ; Thirlwell, C; Brock, CS; Newlands, ES; (2005) Emerging targeted treatments for malignant glioma. Expert Opin Emerg Drugs , 10 (4) pp. 845-854. 10.1517/14728214.10.4.845.

Murphy, RT; Mogensen, J; McGarry, K; Bahl, A; Evans, A; Osman, E; Syrris, P; (2005) Adenosine monophosphate-activated protein kinase disease mimicks hypertrophic cardiomyopathy and Wolff-Parkinson-White syndrome - Natural history. J AM COLL CARDIOL , 45 (6) 922 - 930. 10.1016/j.jacc.2004.11.053.

Murrell, A; Rakyan, VK; Beck, S; (2005) From genome to epigenome. HUM MOL GENET , 14 R3 - R10. 10.1093/hmg/ddi110.

N

Nacheva, E; Brazma, D; Foroni, L; Grace, C; (2005) A genome wide screening for genetic imbalances of CML by array CGH. In: (Proceedings) 34th Annual Meeting of the International-Society-for-Experimental-Hematology. (pp. p. 59). ELSEVIER SCIENCE INC

Nathwani, AC; Davidoff, AM; Linch, DC; (2005) A review of gene therapy for haematological disorders. Br J Haematol , 128 (1) pp. 3-17. 10.1111/j.1365-2141.2004.05231.x.

Nathwani, AC; McIntosh, J; Davidoff, AM; (2005) An update on gene therapy for hemophilia. Curr Hematol Rep , 4 (4) pp. 287-293.

Natkunam, Y; Lossos, IS; Taidi, B; Zhao, S; Lu, X; Ding, F; Hammer, AS; (2005) Expression of the human germinal center-associated lymphoma (HGAL) protein, a new marker of germinal center B-cell derivation. Blood , 105 (10) pp. 3979-3986. 10.1182/blood-2004-08-3112.

Nicholls, BM; Bredius, RGM; Hamdy, NAT; Gerritsen, EJA; Lankester, AC; Hogendoorn, PCW; Nesbitt, SA; (2005) Limited rescue of osteoclast-poor osteopetrosis after successful engraftment by cord blood from an unrelated donor. J BONE MINER RES , 20 (12) 2264 - 2270. 10.1359/JBMR.050807.

Nimmo, R; Antebi, A; Woollard, A; (2005) mab-2 encodes RNT-1, a C-elegans Runx homologue essential for controlling cell proliferation in a stem cell-like developmental lineage. DEVELOPMENT , 132 (22) pp. 5043-5054. 10.1242/dev.02102.

Nooij, MA; Whelan, J; Bramwell, VHC; Taminiau, AT; Cannon, S; Hogendoorn, PCW; Pringle, J; (2005) Doxorubicin and cisplatin chemotherapy in high-grade spindle cell sarcomas of the bone, other than osteosarcoma or malignant fibrous histiocytoma: a European Osteosarcoma Intergroup Study. EUR J CANCER , 41 (2) 225 - 230. 10.1016/j.ejca.2004.08.026.

Norman, MW; Simpson, M; Mogensen, J; Shaw, A; Hughes, S; Sen-Chowdhry, S; Rowland, E; (2005) A novel mutation in desmoplakin causes arrhythmogenic left ventricular cardiomyopathy. Circulation , 112 (5) pp. 636-642. Green open access
file

O

O'Connell, NM; Saunders, RE; Lee, CA; Perry, DJ; Perkins, SJ; (2005) Structural interpretation of 42 mutations causing factor XI deficiency using homology modeling. J THROMB HAEMOST , 3 (1) 127 - 138.

O'Shea, C; Klupsch, K; Choi, S; Bagus, B; Soria, C; Shen, J; McCormick, F; (2005) Adenoviral proteins mimic nutrient/growth signals to activate the mTOR pathway for viral replication. EMBO J , 24 (6) 1211 - 1221. 10.1038/sj.emboj.7600597.

Oakervee, HE; Popat, R; Curry, N; Smith, P; Morris, C; Drake, M; Agrawal, S; (2005) PAD combination therapy (PS-341/bortezomib, doxorubicin and dexamethasone) for previously untreated patients with multiple myeloma. BRITISH JOURNAL OF HAEMATOLOGY , 129 (6) pp. 755-762. 10.1111/j.1365-2141.2005.05519.x.

Obermann, EC; Eward, KL; Dogan, A; Paul, EA; Loddo, M; Munson, P; Williams, GH; (2005) DNA replication licensing in peripheral B-cell lymphoma. J PATHOL , 205 (3) 318 - 328.

Oberst, A; Rossi, M; Salomoni, P; Pandolfi, PP; Oren, M; Melino, G; Bernassola, F; (2005) Regulation of the p73 protein stability and degradation. Biochem Biophys Res Commun , 331 (3) pp. 707-712. 10.1016/j.bbrc.2005.03.158.

Ohkura, N; Takahashi, M; Yaguchi, H; Nagamura, Y; Tsukada, T; (2005) Coactivator-associated arginine methyltransferase 1, CARM1, affects pre-mRNA splicing in an isoform-specific manner. J Biol Chem , 280 (32) pp. 28927-28935. 10.1074/jbc.M502173200. Gold open access

P

Pai, I; Hegde, V; Wilson, PO; Ancliff, P; Ramsay, AD; Daya, H; (2005) Ectopic thymus presenting as a subglottic mass: diagnostic and management dilemmas. Int J Pediatr Otorhinolaryngol , 69 (4) pp. 573-576. 10.1016/j.ijporl.2004.11.022.

Parker, LL; Anderson, FM; O'Hare, CC; Lacy, SM; Bingham, JP; Robins, DJ; Hartley, JA; (2005) Synthesis of novel DNA cross-linking antitumour agents based on polyazamacrocycles. BIOORGAN MED CHEM , 13 (7) 2389 - 2395. 10.1016/j.bmc.2005.01.055.

Pascolo, S; Ginhoux, F; Laham, N; Walter, S; Schoor, O; Probst, J; Rohrlich, P; (2005) The non-classical HLA class I molecule HFE does not influence the NK-like activity contained in fresh human PBMCs and does not interact with NK cells. Int Immunol , 17 (2) pp. 117-122. 10.1093/intimm/dxh191.

Patel, B; Goldstone, AH; Ross, P; Richards, S; Foroni, L; Chopra, R; Fielding, A; (2005) The impact of imatinib therapy on adult Philadelphia positive acute lymphoblastic leukaemia (ALL): Early results from the UKALL12/ECOG 2993 study. In: (Proceedings) 47th Annual Meeting of the American-Society-of-Hematology. (pp. 523A-523A). AMER SOC HEMATOLOGY

Peggs, K.S.; Hunter, A.; Chopra, R.; Parker, A.; Mahendra, P.; Milligan, D.; Craddock, C.; (2005) Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantation. The Lancet , 365 (9475) pp. 1934-1941. 10.1016/S0140-6736(05)66659-7.

Peggs, KS; Allison, JP; (2005) Co-stimulatory pathways in lymphocyte regulation: the immunoglobulin superfamily. BRIT J HAEMATOL , 130 (6) 809 - 824.

Peggs, KS; Hunter, A; Chopra, R; Parker, A; Mahendra, P; Milligan, D; Craddock, C; (2005) Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantation. Lancet , 365 (9475) pp. 1934-1941. 10.1016/S0140-6736(05)66659-7.

Peggs, KS; Hunter, A; Chopra, R; Parker, A; Mahendra, P; Milligan, D; Craddock, C; (2005) Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantation. LANCET , 365 (9475) 1934 - 1941.

Peggs, KS; Mackinnon, S; Linch, DC; (2005) The role of allogeneic transplantation in non-Hodgkin's lymphoma. BRIT J HAEMATOL , 128 (2) 153 - 168. 10.1111/j.1365-2141.2004.05251.x.

Peltenburg, LT; de Bruin, EC; Meersma, D; Smit, NP; Schrier, PI; Medema, JP; (2005) Expression and function of the apoptosis effector Apaf-1 in melanoma. Cell Death Differ , 12 (6) pp. 678-679. 10.1038/sj.cdd.4401630.

Peter, M; Ameer-Beg, SM; Hughes, MKY; Keppler, MD; Prag, S; Marsh, M; Vojnovic, B; (2005) Multiphoton-FLIM quantification of the EGFP-mRFP1 FRET pair for localization of membrane receptor-kinase interactions. BIOPHYSICAL JOURNAL , 88 (2) pp. 1224-1237. 10.1529/biophysj.104.050153.

Pillay, OC; Wong Te Fong, LF; Crow, JC; Benjamin, E; Mould, T; Atiomo, W; Menon, PA; (2005) The association between polycystic ovaries and endometrial cancer. Human Reproduction

Pina, C; Pinto, F; Feijó, JA; Becker, JD; (2005) Gene family analysis of the Arabidopsis pollen transcriptome reveals biological implications for cell growth, division control, and gene expression regulation. Plant Physiol , 138 (2) pp. 744-756. 10.1104/pp.104.057935.

Pinto, ES; Mensah, R; Meeran, K; Cameron, JD; Murugaesu, N; Bulpitt, CJ; Rajkumar, C; (2005) Peripheral arterial compliance differs between races: comparison among Asian, Afro-Caribbeans, and white Caucasians with type 2 diabetes. Diabetes Care , 28 (2) 496-.

Plummer, ER; Middleton, MR; Jones, C; Olsen, A; Hickson, I; McHugh, P; Margison, GP; (2005) Temozolomide pharmacodynamics in patients with metastatic melanoma: DNA damage and activity of repair enzymes 6-alkylguanine alkyltransferase and poly(ADP-ribose) polymerase-1. CLIN CANCER RES , 11 (9) 3402 - 3409.

Pool-Zobel, B; Veeriah, S; Böhmer, FD; (2005) Modulation of xenobiotic metabolising enzymes by anticarcinogens -- focus on glutathione S-transferases and their role as targets of dietary chemoprevention in colorectal carcinogenesis. Mutat Res , 591 (1-2) pp. 74-92. 10.1016/j.mrfmmm.2005.04.020.

Popat, R; Goff, L; Oaekervee, HE; Cavenagh, JD; Joel, SP; (2005) Changes in Mcl-1 and Bim expression with bortezomib and melphalan therapy for multiple myeloma. In: (Proceedings) 47th Annual Meeting of the American-Society-of-Hematology. (pp. 697A-697A). AMER SOC HEMATOLOGY

Popat, R; Oakervee, H; Foot, N; Curry, N; Morris, C; Drake, M; Agrawal, S; (2005) PAD (PS-341/bortezomib, adriamycin and dexamethasone) as front-line therapy for untreated patients with multiple myeloma. In: (Proceedings) 45th Annual Scientific Meeting of the British-Society-for-Haematology. (pp. p. 22). BLACKWELL PUBLISHING

Popat, R; Oakervee, HE; Agrawal, S; Smith, P; Singer, C; Craddock, C; Williams, C; (2005) A phase I/II trial of bortezomib and low dose intravenous melphalan (BM) for relapsed multiple myeloma. In: (Proceedings) 45th Annual Scientific Meeting of the British-Society-for-Haematology. (pp. p. 27). BLACKWELL PUBLISHING

Popat, R; Oakervee, HE; Curry, N; Foot, N; Morris, C; Drake, M; Agrawal, S; (2005) Reduced dose PAD combination therapy (PS-341/bortezomib, adriamycin and dexamethasone) for previously untreated patients with multiple myeloma. In: (Proceedings) 47th Annual Meeting of the American-Society-of-Hematology. (pp. 717A-718A). AMER SOC HEMATOLOGY

Popat, R; Oakervee, HE; Foot, N; Agrawal, S; Smith, P; Craddock, C; Williams, C; (2005) A phase I/II study of bortezomib and low dose intravenous melphalan (BM) for relapsed multiple myeloma. In: (Proceedings) 47th Annual Meeting of the American-Society-of-Hematology. (pp. 718A-718A). AMER SOC HEMATOLOGY

Porter, JB; (2005) Monitoring and treatment of iron overload: State of the art and new approaches. SEMIN HEMATOL , 42 (2) S14 - S18. 10.1053/j.seminhematol.2005.01.004.

Porter, JB; Rafique, R; Srichairatanakool, S; Davis, BA; Shah, FT; Hair, T; Evans, P; (2005) Recent insights into interactions of deferoxamine with cellular and plasma iron pools: Implications for clinical use. COOLEY'S ANEMIA EIGHTH SYMPOSIUM , 1054 155 - 168. 10.1196/annals.1345.018.

Presneau, N; Dewar, K; Forgetta, V; Provencher, D; Mes-Masson, AM; Tonin, PN; (2005) Loss of heterozygosity and transcriptome analyses of a 1.2 Mb candidate ovarian cancer tumor suppressor locus region at 17q25.1-q25.2. MOL CARCINOGEN , 43 (3) 141 - 154. 10.1002/mc.20096.

Presneau, N; Shen, Z; Provencher, D; Mes-Masson, AM; Tonin, PN; (2005) Identification of novel variant, 1484delG in the 3 ' UTR of H3F3B, a member of the histone 3B replacement family, in ovarian tumors. INT J ONCOL , 26 (6) 1621 - 1627.

Price, CA; Lingerfelt, BM; Handl, HL; Kiakos, K; Hartley, JA; Lee, M; (2005) Sequence specific recognition of DNA by tailor-made hairpin conjugates of achiral seco-cyclopropaneindoline-2-benzofurancarboxamide and pyrrole-imidazole polyamides. Bioorg Med Chem Lett , 15 (12) pp. 3151-3156. 10.1016/j.bmcl.2005.04.006.

Puleston, J; Cooper, M; Murch, S; Bid, K; Makh, S; Ashwood, P; Bingham, AH; (2005) A distinct subset of chemokines dominates the mucosal chemokine response in inflammatory bowel disease. ALIMENTARY PHARMACOLOGY & THERAPEUTICS , 21 (2) pp. 109-120. 10.1111/j.1365-2036.2004.02262.x.

Pulè, MA; Straathof, KC; Dotti, G; Heslop, HE; Rooney, CM; Brenner, MK; (2005) A chimeric T cell antigen receptor that augments cytokine release and supports clonal expansion of primary human T cells. Mol Ther , 12 (5) pp. 933-941. 10.1016/j.ymthe.2005.04.016.

Q

Quaglia, A; Etessami, N; Sim, R; Difford, J; Dhillon, AP; (2005) Vascular invasion and herniation by hepatocellular carcinoma in cirrhosis - A wolf in sheep's clothing? ARCH PATHOL LAB MED , 129 (5) 639 - 644.

Quaglia, A; Jutand, MA; Dhillon, A; Godfrey, A; Togni, R; Bioulac-Sage, P; Balabaud, C; (2005) Classification tool for the systematic histological assessment of hepatocellular carcinoma, macroregenerative nodules, and dysplastic nodules in cirrhotic liver. WORLD JOURNAL OF GASTROENTEROLOGY , 11 (40) pp. 6262-6268. Gold open access

Quezada, SA; Bennett, K; Blazar, BR; Rudensky, AY; Sakaguchi, S; Noelle, RJ; (2005) Analysis of the underlying cellular mechanisms of anti-CD154-induced graft tolerance: The interplay of clonal anergy and immune regulation. J IMMUNOL , 175 (2) 771 - 779.

R

Rada-Iglesias, A; Wallerman, O; Koch, C; Ameur, A; Enroth, S; Clelland, G; Wester, K; (2005) Binding sites for metabolic disease related transcription factors inferred at base pair resolution by chromatin immunoprecipitation and genomic microarrays. HUM MOL GENET , 14 (22) 3435 - 3447. 10.1093/hmg/ddi378.

Reid, AG; Nacheva, EP; (2005) Genesis of derivative chromosome 9 deletions in chronic myeloid leukemia. GENE CHROMOSOME CANC , 43 (2) 223 - 224. 10.1002/gcc.20163.

Rew, SB; Peggs, K; Sanjuan, I; Pizzey, AR; Koishihara, Y; Kawai, S; Kosaka, M; (2005) Generation of potent antitumor CTL from patients with multiple myeloma directed against HM1.24. CLIN CANCER RES , 11 (9) 3377 - 3384.

Roberts, C; Ivins, SM; James, CT; Scambler, PJ; (2005) Retinoic acid down-regulates Tbx1 expression in vivo and in vitro. DEV DYNAM , 232 (4) 928 - 938. 10.1002/dvdy.20268.

Robinson, J; Waller, MJ; Stoehr, P; Marsh, SGE; (2005) IPD - the immuno polymorphism database. NUCLEIC ACIDS RESEARCH , 33 D523-D526. 10.1093/nar/gki032. Gold open access

Rodrigues, NP; Janzen, V; Forkert, R; Dombkowski, DM; Boyd, AS; Orkin, SH; Enver, T; (2005) Haploinsufficiency of GATA-2 perturbs adult hematopoietic stem-cell homeostasis. BLOOD , 106 (2) pp. 477-484. 10.1182/blood-2004-08-2989.

Rodriguez, T; Mendez, R; Roberts, CH; Ruiz-Cabello, F; Dodi, IA; Nevot, MAL; Paco, L; (2005) High frequency of homozygosity of the HLA region in melanoma cell lines reveals a pattern compatible with extensive loss of heterozygosity. CANCER IMMUNOLOGY IMMUNOTHERAPY , 54 (2) pp. 141-148. 10.1007/s00262-004-0561-5.

Rodriguez-Viciana, P; McCormick, F; (2005) RaIGDS comes of age. CANCER CELL , 7 (3) 205 - 206.

Rodriguez-Viciana, P; Tetsu, O; Oda, K; Okada, J; Rauen, K; McCormick, F; (2005) Cancer targets in the Ras pathway. Molecular Approaches to Controlling Cancer , 70 461 - 467.

Rogers, SL; Gobel, TW; Viertlboeck, BC; Milne, S; Beck, S; Kaufman, J; (2005) Characterization of the chicken C-type lectin-like receptors B-NK and B-lec suggests that the NK complex and the MHC share a common ancestral region. J IMMUNOL , 174 (6) 3475 - 3483.

Rohn, JL; Zhang, YH; Leliveld, SR; Danen-van Oorschot, AA; Henriquez, NV; Abrahams, JP; Noteborn, MH; (2005) Relevance of apoptin's integrity for its functional behavior. J Virol , 79 (2) pp. 1337-1338. 10.1128/JVI.79.2.1337-1338.2005.

Ross, MT; Grafham, DV; Coffey, AJ; Scherer, S; McLay, K; Muzny, D; Platzer, M; (2005) The DNA sequence of the human X chromosome. NATURE , 434 (7031) 325 - 337. 10.1038/nature03440.

Rubio, MT; Means, TK; Chakraverty, R; Shaffer, J; Fudaba, Y; Chittenden, M; Luster, AD; (2005) Maturation of human monocyte-derived dendritic cells (MoDCs) in the presence of prostaglandin E-2 optimizes CD4 and CD8 T cell-mediated responses to protein antigens: role of PGE(2) in chemokine and cytokine expression by MoDCs. INTERNATIONAL IMMUNOLOGY , 17 (12) pp. 1561-1572. 10.1093/intimm/dxh335.

Rudd, R.M.; Gower, N.H.; Spiro, S.G.; Eisen, T.G.; Harper, P.G.; Littler, J.A.H.; Hatton, M.; (2005) Gemcitabine plus Carboplatin versus Mitomycin, Ifosfamide, and Cisplatin in patients with stage IIIB or IV non–small-cell lung cancer: a phase III randomized study of the London Lung Cancer Group. Journal of Clinical Oncology , 23 (1) pp. 142-153. Green open access
file

Rudd, R.M.; Gower, N.H.; Spiro, S.G.; Eisen, T.G.; Harper, P.G.; Littler, J.A.H.; Hatton, M.; (2005) Gemcitabine plus carboplatin versus mitomycin, ifosfamide, and cisplatin in patients with stage IIIB or IV non-small-cell lung cancer: a phase III randomized study of the London Lung Cancer Group. Journal of Clinical Oncology , 23 (1) pp. 142-153. 10.1200/JCO.2005.03.037.

Rudd, RM; Gower, NH; Spiro, SG; Eisen, TG; Harper, PG; Littler, JAH; Hatton, M; (2005) Gemcitabine plus carboplatin versus mitomycin, ifosfamide, and cisplatin in patients with stage IIIB or IV non-small-cell lung cancer: A phase III randomized study of the London Lung Cancer Group. JOURNAL OF CLINICAL ONCOLOGY , 23 (1) pp. 142-153. 10.1200/JCO.2005.03.037.

S

Sabin, CA; Phillips, AN; Yee, TT; Griffioen, A; Lee, CA; (2005) Twenty five years of HIV infection in haemophilic men in Britain: an observational study. BRIT MED J , 331 (7523) 997 - 998. 10.1136/bmj.38604.468785.DE. Gold open access

Saich, R; Collins, P; Ala, A; Standish, R; Hodgson, H; (2005) Benign recurrent intrahepatic cholestasis with secondary renal impairment treated with extracorporeal albumin dialysis. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY , 17 (5) pp. 585-588. 10.1097/00042737-200505000-00018.

Salomoni, P; Bernardi, R; Bergmann, S; Changou, A; Tuttle, S; Pandolfi, PP; (2005) The promyelocytic leukemia protein PML regulates c-Jun function in response to DNA damage. BLOOD , 105 (9) 3686 - 3690. 10.1182/blood-2004-09-3782.

Salomoni, P; Dyer, MJS; (2005) Delta N-p73: the enemy within. CELL DEATH DIFFER , 12 (12) 1553 - 1554. 10.1038/sj.cdd.4401802.

Sambrook, JG; Bashirova, A; Palmer, S; Sims, S; Trowsdale, J; Abi-Rached, L; Parham, P; (2005) Single haplotype analysis demonstrates rapid evolution of the killer immunoglobulin-like receptor (KIR) loci in primates. GENOME RES , 15 (1) 25 - 35. 10.1101/gr.2381205.

Sambrook, JG; Figueroa, F; Beck, S; (2005) A genome-wide survey of Major Histocompatibility Complex (MHC) genes and their paralogues in zebrafish. BMC GENOMICS , 6 , Article 152. 10.1186/1471-2164-6-152. Green open access
file

Samonakis, DN; Cholongitas, E; Triantos, CK; Griffiths, P; Dhillon, AP; Thalheimer, U; Patch, DW; (2005) Sustained, spontaneous disappearance of serum HCV-RNA under immunosuppression after liver transplantion for HCV cirrhosis. J HEPATOL , 43 (6) 1091 - 1093. 10.1016/j.jhep.2005.08.005.

Samonakis, DN; Cholongitas, E; Triantos, CK; Quaglia, A; Senzolo, M; Dhillon, AP; Sharma, D; (2005) Randomised trial of tacrolimus monotherapy vs. tacrolimus/azathioprine/prednisolone after liver transplantation for HCV cirrhosis: Preliminary results. JOURNAL OF HEPATOLOGY , 42 47 - 47.

Samonakis, DN; Quaglia, A; Joshi, NM; Tibballs, JM; Nagree, A; Triantos, CK; Davies, N; (2005) Obstructive jaundice secondary to neuroendocrine tumour in a patient with von Recklinghausen's disease. Eur J Gastroenterol Hepatol , 17 (11) pp. 1229-1232.

Samonakis, DN; Triantos, CK; Thalheimer, U; Quaglia, A; Leandro, G; Teixeira, R; Papatheodoridis, GV; (2005) Immunosuppression and donor age with respect to severity of HCV recurrence after liver transplantation. LIVER TRANSPLANT , 11 (4) 386 - 395. 10.1002/lt.20344.

Sato, A; McNulty, L; Cox, K; Kim, S; Scott, A; Daniell, K; Summerville, K; (2005) A novel class of in vivo active anticancer agents: achiral seco-amino- and seco-hydroxycyclopropylbenz[e]indolone (seco-CBI) analogues of the duocarmycins and CC-1065. J Med Chem , 48 (11) pp. 3903-3918. 10.1021/jm050179u.

Sato, A; McNulty, LA; Cox, K; Kim, S; Scott, A; Daniell, K; Summerville, K; (2005) A novel class of in vivo active anticancer agents: Achiral seco-amino- and seco-hydroxycyclopropylbenz[e]indolone (seco-CBI) analogues of the duocarmycins and CC-1065. J MED CHEM , 48 (11) 3903 - 3918. 10.1021/jm050179u.

Schreuder, GMT; Hurley, CK; Marsh, SGE; Lau, M; Fernandez-Vina, M; Noreen, HJ; Setterholm, M; (2005) The HLA Dictionary 2004: a summary of HLA-A, -B, -C,-DRB1/3/4/5 and -DQB1 alleles and their association with serologically defined HLAA -B, -C, -DR and -DQ antigens. INTERNATIONAL JOURNAL OF IMMUNOGENETICS , 32 (1) pp. 19-69. 10.1111/j.1744-313X.2005.00497.x.

Schreuder, GMT; Hurley, CK; Marsh, SGE; Lau, M; Fernandez-Vina, M; Noreen, HJ; Setterholm, M; (2005) The HLA Dictionary 2004: a summary of HLA-A, -B, -C,-DRB1/3/4/5 and-DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR and -DQ antigens. TISSUE ANTIGENS , 65 (1) pp. 1-55. 10.1111/j.1399-0039.2004.00350.x.

Schuh, AH; Tipping, AJ; Clark, AJ; Hamlett, I; Guyot, B; Iborra, FJ; Rodriguez, P; (2005) ETO-2 associates with SCL in erythroid cells and megakaryocytes and provides repressor functions in erythropoiesis. MOL CELL BIOL , 25 (23) 10235 - 10250. 10.1128/MCB.25.23.10235-10250.2005.

Seddon, BM; Cassoni, AM; Galloway, MJ; Rees, JH; Whelan, JS; (2005) Fatal radiation myelopathy after high-dose busulfan and melphalan chemotherapy and radiotherapy for Ewing's sarcoma: A review of the literature and implications for practice. CLIN ONCOL-UK , 17 (5) 385 - 390. 10.1016/j.clon.2005.03.004.

Seldon, PM; Meja, KK; Giembycz, MA; (2005) Rolipram, salbutamol and prostaglandin E2 suppress TNFalpha release from human monocytes by activating Type II cAMP-dependent protein kinase. Pulm Pharmacol Ther , 18 (4) pp. 277-284. 10.1016/j.pupt.2004.12.012.

Senis, YA; Atkinson, BT; Pearce, AC; Wonerow, P; Auger, JM; Okkenhaug, K; Pearce, W; (2005) Role of the p110 delta PI 3-kinase in integrin and ITAM receptor signalling in platelets. PLATELETS , 16 (3-4) pp. 191-202. 10.1080/09537100400016711.

Shah, JS; Hughes, DA; Sachdev, B; Tome, M; Ward, D; Lee, P; Mehta, AB; (2005) Prevalence and clinical significance of cardiac arrhythmia in Anderson-Fabry disease. AM J CARDIOL , 96 (6) 842 - 846. 10.1016/j.amjcard.2005.05.033.

Shah, JS; Lee, P; Hughes, D; Thaman, R; Sachdev, B; Pellerin, D; Mehta, A; (2005) The natural history of left ventricular systolic function in Anderson-Fabry disease. HEART , 91 (4) 533 - 534. 10.1136/hrt.2004.035584.

Sharma, S.K.; Pedley, R.B.; Bhatia, J.; Boxer, G.M.; El-Emir, E.; Qureshi, U.; Tolner, B.; (2005) Sustained tumor regression of human colorectal cancer xenografts using a multifunctional mannosylated fusion protein in antibody-directed enzyme prodrug therapy. Clinical Cancer Research , 11 (2) pp. 814-825.

Sharma, SK; Bagshawe, KD; Begent, RH; (2005) Advances in antibody-directed enzyme prodrug therapy. Curr Opin Investig Drugs , 6 (6) pp. 611-615.

Sharma, SK; Griffin, N; Mayer, A; Tolner, B; Shahbakhti, H; Chester, KA; Begent, RHJ; (2005) Immunogenicity of a glycosylates antibody-enzyme fusion protien (MFECP1) in a phase I/II clinical study of ADEPT. Presented at: NCRI Cancer Conference Proceedings.

Sharma, SK; Pedley, RB; Bhatia, J; Boxer, GM; El-Emir, E; Qureshi, U; Tolner, B; (2005) Sustained tumor regression of human colorectal cancer xenografts using a multifunctional mannosylated fusion protein in antibody-directed enzyme prodrug therapy. CLIN CANCER RES , 11 (2) 814 - 825.

Shaw, BE; Russell, NH; Devereux, S; Das-Gupta, E; MacKinnon, S; Madrigal, JA; Pagliuca, A; (2005) The impact of donor factors on primary non-engraftment in recipients of reduced intensity conditioned transplants from unrelated donors. HAEMATOL-HEMATOL J , 90 (11) 1562 - 1569. Gold open access

Shetty, A; Loddo, M; Fanshawe, T; Prevost, AT; Sainsbury, R; Williams, GH; Stoeber, K; (2005) DNA replication licensing and cell cycle kinetics of normal and neoplastic breast. BRIT J CANCER , 93 (11) 1295 - 1300. 10.1038/sj.bjc.6602829. Gold open access

Sieben, NLG; Oosting, J; Flanagan, AM; Prat, J; Roemen, GMJM; Kolkman-Uljee, SM; van Eijk, R; (2005) Differential gene expression in ovarian tumors reveals Dusp 4 and Serpina 5 as key regulators for benign behavior of serous borderline tumors. J CLIN ONCOL , 23 (29) 7257 - 7264. 10.1200/JCO.2005.02.2541.

Simon, M; Grandage, VL; Linch, DC; Khwaja, A; (2005) Constitutive activation of the Wnt/ss-catenin signalling pathway in acute myeloid leukaemia. ONCOGENE , 24 (14) 2410 - 2420. 10.1038/sj.onc.1208431.

Simon, M; Grandage, VL; Linch, DC; Khwaja, A; (2005) Constitutive activation of the Wnt/β-catenin signalling pathway in acute myeloid leukaemia. Oncogene , 24 (14) pp. 2410-2420. 10.1038/sj.onc.1208431.

Song, L; Zlobin, A; Ghoshal, P; Zhang, Q; Houde, C; Weijzen, S; Jiang, Q; (2005) Alteration of SMRT tumor suppressor function in transformed non-Hodgkin lymphomas. Cancer Res , 65 (11) pp. 4554-4561. 10.1158/0008-5472.CAN-04-4108.

Starke, R; Harrison, P; Mackie, I; Wang, G; Erusalimsky, JD; Gale, R; Masse, JM; (2005) The expression of prion protein (PrPc) in the megakaryocyte lineage. J THROMB HAEMOST , 3 (6) 1266 - 1273.

Starke, R; Harrison, P; Mackie, I; Wang, G; Erusalimsky, JD; Gale, R; Massé, JM; (2005) The expression of prion protein (PrP<sup>C</sup>) in the megakaryocyte lineage. Journal of Thrombosis and Haemostasis , 3 (6) pp. 1266-1273. 10.1111/j.1538-7836.2005.01343.x.

Steele, AJ; Al-Chalabi, A; Ferrante, K; Cudkowicz, ME; Brown, RH; Garson, JA; (2005) Detection of serum reverse transcriptase activity in patients with ALS and unaffected blood relatives. NEUROLOGY , 64 (3) 454 - 458.

Stegert, MR; Hergovich, A; Tamaskovic, R; Bichsel, SJ; Hemmings, BA; (2005) Regulation of NDR protein kinase by hydrophobic motif phosphorylation mediated by the mammalian Ste20-like kinase MST3. MOL CELL BIOL , 25 (24) 11019 - 11029. 10.1128/MCB.25.24.11019-11029.2005.

Stephens, P; Edkins, S; Davies, H; Greenman, C; Cox, C; Hunter, C; Bignell, G; (2005) A screen of the complete protein kinase gene family identifies diverse patterns of somatic mutations in human breast cancer. NAT GENET , 37 (6) 590 - 592. 10.1038/ng1571.

Steward, CG; Blair, A; Moppett, J; Clarke, E; Virgo, P; Lankester, A; Burger, SR; (2005) High peripheral blood progenitor cell counts enable autologous backup before stem cell transplantation for malignant infantile osteopetrosis. BIOL BLOOD MARROW TR , 11 (2) 115 - 121. 10.1016/j.bbmt.2004.11.001.

Straathof, KC; Pulè, MA; Yotnda, P; Dotti, G; Vanin, EF; Brenner, MK; Heslop, HE; (2005) An inducible caspase 9 safety switch for T-cell therapy. Blood , 105 (11) pp. 4247-4254. 10.1182/blood-2004-11-4564. Green open access
file

Streck, CJ; Dickson, PV; Catherine, YIG; Zhou, JF; Gray, JT; Nathwani, AC; Davidoff, AM; (2005) Adeno-associated virus vector-mediated systemic delivery of IFN-beta combined with low-dose cyclophosphamide affects tumor regression in murine neuroblastoma models. CLIN CANCER RES , 11 (16) 6020 - 6029. 10.1158/1078-0432.CCR-05-0502.

Streck, CJ; Ng, CYC; Zhang, YB; Zhou, JF; Nathwani, AC; Davidoff, AM; (2005) Interferon-mediated anti-angiogenic therapy for neuroblastoma. CANCER LETT , 228 (1-2) 163 - 170. 10.1016/j.canlet.2004.11.063.

Streck, CJ; Zhang, YB; Zhou, JF; Ng, C; Nathwani, AC; Davidoff, AM; (2005) Adeno-associated virus vector-mediated delivery of pigment epithelium-derived factor restricts neuroblastoma angiogenesis and growth. JOURNAL OF PEDIATRIC SURGERY , 40 (1) 236 - 243. 10.1016/j.jpedsurg.2004.09.049.

Stubbs, M; Khan, K; Wickremasinghe, RG; Ganeshaguru, K; Caplin, ME; (2005) CCK2 gastrin receptor as a potential target for therapy in leukaemia cell lines. ONCOL REP , 14 (4) 1055 - 1058.

Sujobert, P; Bardet, V; Cornillet-Lefebvre, P; Hayflick, JS; Prie, N; Verdier, F; Vanhaesebroeck, B; (2005) Essential role for the p110 delta isoform in phosphoinositide 3-kinase activation and cell proliferation in acute myeloid leukemia. BLOOD , 106 (3) pp. 1063-1066. 10.1128/blood-2004-08-3225.

Sánchez-Sánchez, F; Kruetzfeldt, M; Nájera, C; Mittnacht, S; (2005) A novel constitutional mutation affecting splicing of retinoblastoma tumor suppressor gene intron 23 causes partial loss of pRB activity. Hum Mutat , 25 (2) 223-. 10.1002/humu.9305.

T

Taher, A; Sheikh-Taha, M; Sharara, A; Inati, A; Koussa, S; Ellis, G; Dhillon, AP; (2005) Safety and effectiveness of 100 mg/kg/day deferiprone in patients with thalassemia major: A two-year study. ACTA HAEMATOL-BASEL , 114 (3) 146 - 149. 10.1159/000087888.

Tan, SV; Lee, PJ; Walters, RJL; Mehta, A; Bostock, H; (2005) Evidence for motor axon depolarization in Fabry disease. MUSCLE & NERVE , 32 (4) 548 - 551. 10.1002/mus.20390.

Tauro, S; Craddock, C; Peggs, K; Begum, G; Mahendra, P; Cook, G; Marsh, J; (2005) Allogeneic stem-cell transplantation using a reduced-intensity conditioning regimen has the capacity to produce durable remissions and long-term disease-free survival in patients with high-risk acute myeloid leukemia and myelodysplasia. J CLIN ONCOL , 23 (36) 9387 - 9393. 10.1200/JCO.2005.02.0057.

Thom, M; Martinian, L; Sisodiya, SM; Cross, JH; Williams, G; Stoeber, K; Harkness, W; (2005) Mcm2 labelling of balloon cells in focal cortical dysplasia. NEUROPATH APPL NEURO , 31 (6) 580 - 588. 10.1111/j.1365-2990.2005.00651.x.

Thom, M; Martinian, L; Williams, G; Stoeber, K; Cross, H; Harding, BN; Sisodiya, SM; (2005) Geminin expression in balloon cells in focal cortical dysplasia (FCD) type IIB. EPILEPSIA , 46 368 - 368.

Thom, M; Martinian, L; Williams, G; Stoeber, K; Sisodiya, SM; (2005) Cell proliferation and granule cell dispersion in human hippocampal sclerosis. J NEUROPATH EXP NEUR , 64 (3) 194 - 201.

Thomas, MJ; Smith, A; Head, DH; Milne, L; Nicholls, A; Pearce, W; Vanhaesebroeck, B; (2005) Airway inflammation: chemokine-induced neutrophilia and the class I phosphoinositide 3-kinases. EUROPEAN JOURNAL OF IMMUNOLOGY , 35 (4) pp. 1283-1291. 10.1002/eji.200425634.

Thomson, KJ; Hart, DP; Banerjee, L; Ward, KN; Peggs, KS; Mackinnon, S; (2005) The effect of low-dose aciclovir on reactivation of varicella zoster virus after allogeneic haemopoietic stem cell transplantation. BONE MARROW TRANSPL , 35 (11) 1065 - 1069. 10.1038/sj.bmt.1704959.

Thomson, KJ; Peggs, KS; (2005) Role of allogeneic stem cell transplantation in multiple myeloma. EXPERT REV ANTICANC , 5 (3) 455 - 464. 10.1586/14737140.5.3.455.

Tominaga, Y; Tamgüney, T; Kolesnichenko, M; Bilanges, B; Stokoe, D; (2005) Translational deregulation in PDK-1-/- embryonic stem cells. Mol Cell Biol , 25 (19) pp. 8465-8475. 10.1128/MCB.25.19.8465-8475.2005.

Torres-Rendon, A; Craig, GT; Loddo, M; Stoeber, K; Williams, GH; Speight, PM; (2005) Expression of novel cell cycle markers in normal oral mucosa and oral epithelial dysplasias. In: ORAL ONCOLOGY. (pp. 86 - 86). ELSEVIER SCIENCE BV

Toth, JL; Trzupek, JD; Flores, LV; Kiakos, K; Hartley, JA; Pennington, WT; Lee, M; (2005) A novel achiral seco-amino-cyclopropylindoline (CI) analog of CC-1065 and the duocarmycins: design, synthesis and biological studies. Med Chem , 1 (1) pp. 13-19.

V

Vanhaesebroeck, B; Ali, K; Bilancio, A; Geering, B; Foukas, LC; (2005) Signalling by PI3K isoforms: insights from gene-targeted mice. TRENDS IN BIOCHEMICAL SCIENCES , 30 (4) pp. 194-204. 10.1016/j.tibs.2005.02.008.

Vaquerizas, JM; Conde, L; Yankilevich, P; Cabezon, A; Minguez, P; Diaz-Uriarte, R; Al-Shahrour, F; (2005) GEPAS, an experiment-oriented pipeline for the analysis of microarray gene expression data. NUCLEIC ACIDS RESEARCH , 33 W616-W620. 10.1093/nar/gki500.

Viviani, B; Bartesaghi, S; Corsini, E; Villa, P; Ghezzi, P; Garau, A; Galli, CL; (2005) Erythropoietin protects primary hippocampal neurons increasing the expression of brain-derived neurotrophic factor. J NEUROCHEM , 93 (2) 412 - 421. 10.1111/j.1471-4159.2005.03033.x.

Vogt, G; Chapgier, A; Yang, K; Chuzhanova, N; Feinberg, J; Fieschi, C; Boisson-Dupuis, S; (2005) Gains of glycosylation comprise an unexpectedly large group of pathogenic mutations. Nat Genet , 37 (7) pp. 692-700. 10.1038/ng1581.

van Duin, M; van Marion, R; Watson, JEV; Paris, PL; Lapuk, A; Brown, N; Oseroff, VV; (2005) Construction and application of a full-coverage high-resolution, human chromosome 8q genomic microarray for comparative genomic hybridization. In: CYTOM PART A. (pp. 10 - 19). WILEY-LISS

W

Wald, NJ; Rodeck, C; Hackshaw, AK; Rudnicka, A; (2005) SURUSS in perspective. SEMINARS IN PERINATOLOGY , 29 (4) 225 - 235. 10.1053/j.semperi.2005.05.006.

Walker, BA; van Hateren, A; Milne, S; Beck, S; Kaufman, J; (2005) Chicken TAP genes differ from their human orthologues in locus organisation, size, sequence features and polymorphism. IMMUNOGENETICS , 57 (3-4) 232 - 247. 10.1007/s00251-005-0786-2.

Wang, HW; Boshoff, C; (2005) Linking Kaposi virus to cancer-associated cytokines. TRENDS MOL MED , 11 (7) 309 - 312.

Westerman, MP; Pizzey, A; Hirshman, J; Cerino, M; Eze, A; Lawrie, A; Purdie, G; (2005) Hydroxyurea treated sickle disorders demonstrate decreased plasma Hb, red cell vesicles and thrombolysis. In: BLOOD. (pp. 653A - 653A). AMER SOC HEMATOLOGY

Westin, J; Lagging, LM; Dhillon, AP; Hellstrand, K; Norkrans, G; Romero, A; Pawlotsky, JM; (2005) Steatosis does not affect the result of antiviral treatment in HCV genotype 3 infected patients. In: JOURNAL OF HEPATOLOGY. (pp. 227 - 227). ELSEVIER SCIENCE BV

Westwood, MA; Wonke, B; Maceira, AM; Prescott, E; Walker, JM; Porter, JB; Pennell, DJ; (2005) Left ventricular diastolic function compared with T2*cardiovascular magnetic resonance for early detection of myocardial iron overload in thalassemia major. J MAGN RESON IMAGING , 22 (2) 229 - 233. 10.1002/jmri.20379.

Wharton, SB; Williams, GH; Stoeber, K; Gelsthorpe, CH; Baxter, L; Johnson, AL; Ince, PG; (2005) Expression of Ki67, PCNA and the chromosome replication licensing protein Mcm2 in glial cells of the ageing human hippocampus increases with the burden of Alzheimer-type pathology. NEUROSCI LETT , 383 (1-2) 33 - 38. 10.1016/j.neulet.2005.04.019.

Y

Yarranton, H; Lawrie, AS; Mackie, IJ; Pinkoski, L; Corash, L; Machin, SJ; (2005) Coagulation factor levels in cryosupernatant prepared from plasma treated with amotosalen hydrochloride (S-59) and ultraviolet A light. TRANSFUSION , 45 (9) 1453 - 1458. 10.1111/j.1537-2995.2005.00551.x.

Z

Zhang, X; Odom, DT; Koo, SH; Conkright, MD; Canettieri, G; Best, J; Chen, H; (2005) Genome-wide analysis of cAMP-response element binding protein occupancy, phosphorylation, and target gene activation in human tissues. Proc Natl Acad Sci U S A , 102 (12) pp. 4459-4464. 10.1073/pnas.0501076102.

This list was generated on Sun Nov 20 06:16:29 2016 GMT.